#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Combining multi-modality data for searching biomarkers in schizophrenia Identification of imaging biomarkers for schizophrenia is an important but still challenging problem.
1-1	0-9	Combining	_
1-2	10-24	multi-modality	_
1-3	25-29	data	_
1-4	30-33	for	_
1-5	34-43	searching	_
1-6	44-54	biomarkers	_
1-7	55-57	in	_
1-8	58-71	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	72-86	Identification	_
1-10	87-89	of	_
1-11	90-97	imaging	_
1-12	98-108	biomarkers	_
1-13	109-112	for	_
1-14	113-126	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-15	127-129	is	_
1-16	130-132	an	_
1-17	133-142	important	_
1-18	143-146	but	_
1-19	147-152	still	_
1-20	153-164	challenging	_
1-21	165-172	problem	_
1-22	173-174	.	_

Text=Even though considerable efforts have been made over the past decades, quantitative alterations between patients and healthy subjects have not yet provided a diagnostic measure with sufficient high sensitivity and specificity.
2-1	175-179	Even	_
2-2	180-186	though	_
2-3	187-199	considerable	_
2-4	200-207	efforts	_
2-5	208-212	have	_
2-6	213-217	been	_
2-7	218-222	made	_
2-8	223-227	over	_
2-9	228-231	the	_
2-10	232-236	past	_
2-11	237-244	decades	_
2-12	245-246	,	_
2-13	247-259	quantitative	_
2-14	260-271	alterations	_
2-15	272-279	between	_
2-16	280-288	patients	_
2-17	289-292	and	_
2-18	293-300	healthy	_
2-19	301-309	subjects	_
2-20	310-314	have	_
2-21	315-318	not	_
2-22	319-322	yet	_
2-23	323-331	provided	_
2-24	332-333	a	_
2-25	334-344	diagnostic	_
2-26	345-352	measure	_
2-27	353-357	with	_
2-28	358-368	sufficient	_
2-29	369-373	high	_
2-30	374-385	sensitivity	_
2-31	386-389	and	_
2-32	390-401	specificity	_
2-33	402-403	.	_

Text=One of the most important reasons is the lack of consistent findings, which is in part due to single-mode study, which only detects single dimensional information by each modality, and thus misses the most crucial differences between groups.
3-1	404-407	One	_
3-2	408-410	of	_
3-3	411-414	the	_
3-4	415-419	most	_
3-5	420-429	important	_
3-6	430-437	reasons	_
3-7	438-440	is	_
3-8	441-444	the	_
3-9	445-449	lack	_
3-10	450-452	of	_
3-11	453-463	consistent	_
3-12	464-472	findings	_
3-13	473-474	,	_
3-14	475-480	which	_
3-15	481-483	is	_
3-16	484-486	in	_
3-17	487-491	part	_
3-18	492-495	due	_
3-19	496-498	to	_
3-20	499-510	single-mode	_
3-21	511-516	study	_
3-22	517-518	,	_
3-23	519-524	which	_
3-24	525-529	only	_
3-25	530-537	detects	_
3-26	538-544	single	_
3-27	545-556	dimensional	_
3-28	557-568	information	_
3-29	569-571	by	_
3-30	572-576	each	_
3-31	577-585	modality	_
3-32	586-587	,	_
3-33	588-591	and	_
3-34	592-596	thus	_
3-35	597-603	misses	_
3-36	604-607	the	_
3-37	608-612	most	_
3-38	613-620	crucial	_
3-39	621-632	differences	_
3-40	633-640	between	_
3-41	641-647	groups	_
3-42	648-649	.	_

Text=Here, we hypothesize that multimodal integration of functional MRI (fMRI), structural MRI (sMRI), and diffusion tensor imaging (DTI) might yield more power for the diagnosis of schizophrenia.
4-1	650-654	Here	_
4-2	655-656	,	_
4-3	657-659	we	_
4-4	660-671	hypothesize	_
4-5	672-676	that	_
4-6	677-687	multimodal	_
4-7	688-699	integration	_
4-8	700-702	of	_
4-9	703-713	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-10	714-717	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-11	718-719	(	_
4-12	720-724	fMRI	_
4-13	725-726	)	_
4-14	727-728	,	_
4-15	729-739	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
4-16	740-743	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
4-17	744-745	(	_
4-18	746-750	sMRI	_
4-19	751-752	)	_
4-20	753-754	,	_
4-21	755-758	and	_
4-22	759-768	diffusion	_
4-23	769-775	tensor	_
4-24	776-783	imaging	_
4-25	784-785	(	_
4-26	786-789	DTI	_
4-27	790-791	)	_
4-28	792-797	might	_
4-29	798-803	yield	_
4-30	804-808	more	_
4-31	809-814	power	_
4-32	815-818	for	_
4-33	819-822	the	_
4-34	823-832	diagnosis	_
4-35	833-835	of	_
4-36	836-849	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-37	850-851	.	_

Text=A novel multivariate data fusion method for combining these modalities is introduced without reducing the dimension or using the priors from 161 schizophrenia patients and 168 matched healthy controls.
5-1	852-853	A	_
5-2	854-859	novel	_
5-3	860-872	multivariate	_
5-4	873-877	data	_
5-5	878-884	fusion	_
5-6	885-891	method	_
5-7	892-895	for	_
5-8	896-905	combining	_
5-9	906-911	these	_
5-10	912-922	modalities	_
5-11	923-925	is	_
5-12	926-936	introduced	_
5-13	937-944	without	_
5-14	945-953	reducing	_
5-15	954-957	the	_
5-16	958-967	dimension	_
5-17	968-970	or	_
5-18	971-976	using	_
5-19	977-980	the	_
5-20	981-987	priors	_
5-21	988-992	from	_
5-22	993-996	161	_
5-23	997-1010	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-24	1011-1019	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-25	1020-1023	and	_
5-26	1024-1027	168	_
5-27	1028-1035	matched	_
5-28	1036-1043	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-29	1044-1052	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-30	1053-1054	.	_

Text=The multi-index feature for each ROI is constructed and summarized with Wilk's lambda by performing multivariate analysis of variance to calculate the significant difference between different groups.
6-1	1055-1058	The	_
6-2	1059-1070	multi-index	_
6-3	1071-1078	feature	_
6-4	1079-1082	for	_
6-5	1083-1087	each	_
6-6	1088-1091	ROI	_
6-7	1092-1094	is	_
6-8	1095-1106	constructed	_
6-9	1107-1110	and	_
6-10	1111-1121	summarized	_
6-11	1122-1126	with	_
6-12	1127-1131	Wilk	_
6-13	1132-1134	's	_
6-14	1135-1141	lambda	_
6-15	1142-1144	by	_
6-16	1145-1155	performing	_
6-17	1156-1168	multivariate	_
6-18	1169-1177	analysis	_
6-19	1178-1180	of	_
6-20	1181-1189	variance	_
6-21	1190-1192	to	_
6-22	1193-1202	calculate	_
6-23	1203-1206	the	_
6-24	1207-1218	significant	_
6-25	1219-1229	difference	_
6-26	1230-1237	between	_
6-27	1238-1247	different	_
6-28	1248-1254	groups	_
6-29	1255-1256	.	_

Text=Our results show that, among these modalities, fMRI has the most significant featureby calculating the Jaccard similarity coefficient (0.7416) and Kappa index (0.4833).
7-1	1257-1260	Our	_
7-2	1261-1268	results	_
7-3	1269-1273	show	_
7-4	1274-1278	that	_
7-5	1279-1280	,	_
7-6	1281-1286	among	_
7-7	1287-1292	these	_
7-8	1293-1303	modalities	_
7-9	1304-1305	,	_
7-10	1306-1310	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
7-11	1311-1314	has	_
7-12	1315-1318	the	_
7-13	1319-1323	most	_
7-14	1324-1335	significant	_
7-15	1336-1345	featureby	_
7-16	1346-1357	calculating	_
7-17	1358-1361	the	_
7-18	1362-1369	Jaccard	_
7-19	1370-1380	similarity	_
7-20	1381-1392	coefficient	_
7-21	1393-1394	(	_
7-22	1395-1401	0.7416	_
7-23	1402-1403	)	_
7-24	1404-1407	and	_
7-25	1408-1413	Kappa	_
7-26	1414-1419	index	_
7-27	1420-1421	(	_
7-28	1422-1428	0.4833	_
7-29	1429-1430	)	_
7-30	1431-1432	.	_

Text=Furthermore, fusion of these modalities provides the most plentiful information and the highest predictive accuracy of 86.52%.
8-1	1433-1444	Furthermore	_
8-2	1445-1446	,	_
8-3	1447-1453	fusion	_
8-4	1454-1456	of	_
8-5	1457-1462	these	_
8-6	1463-1473	modalities	_
8-7	1474-1482	provides	_
8-8	1483-1486	the	_
8-9	1487-1491	most	_
8-10	1492-1501	plentiful	_
8-11	1502-1513	information	_
8-12	1514-1517	and	_
8-13	1518-1521	the	_
8-14	1522-1529	highest	_
8-15	1530-1540	predictive	_
8-16	1541-1549	accuracy	_
8-17	1550-1552	of	_
8-18	1553-1558	86.52	_
8-19	1559-1560	%	_
8-20	1561-1562	.	_

Text=This work indicates that multimodal integration can improve the ability of distinguishing differences between groups and might be assisting in further diagnosis of schizophrenia.
9-1	1563-1567	This	_
9-2	1568-1572	work	_
9-3	1573-1582	indicates	_
9-4	1583-1587	that	_
9-5	1588-1598	multimodal	_
9-6	1599-1610	integration	_
9-7	1611-1614	can	_
9-8	1615-1622	improve	_
9-9	1623-1626	the	_
9-10	1627-1634	ability	_
9-11	1635-1637	of	_
9-12	1638-1652	distinguishing	_
9-13	1653-1664	differences	_
9-14	1665-1672	between	_
9-15	1673-1679	groups	_
9-16	1680-1683	and	_
9-17	1684-1689	might	_
9-18	1690-1692	be	_
9-19	1693-1702	assisting	_
9-20	1703-1705	in	_
9-21	1706-1713	further	_
9-22	1714-1723	diagnosis	_
9-23	1724-1726	of	_
9-24	1727-1740	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-25	1741-1742	.	_

Text=Methods Subjects One hundred and sixty-one patients with chronic schizophrenia (66 males and 95 females) were recruited for this study and they were identified according to the DSM-IV diagnostic criteria by qualified psychiatrists at the Taipei Veterans General Hospital.
10-1	1743-1750	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
10-2	1751-1759	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
10-3	1760-1763	One	_
10-4	1764-1771	hundred	_
10-5	1772-1775	and	_
10-6	1776-1785	sixty-one	_
10-7	1786-1794	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-8	1795-1799	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-9	1800-1807	chronic	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-10	1808-1821	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-11	1822-1823	(	_
10-12	1824-1826	66	_
10-13	1827-1832	males	_
10-14	1833-1836	and	_
10-15	1837-1839	95	_
10-16	1840-1847	females	_
10-17	1848-1849	)	_
10-18	1850-1854	were	_
10-19	1855-1864	recruited	_
10-20	1865-1868	for	_
10-21	1869-1873	this	_
10-22	1874-1879	study	_
10-23	1880-1883	and	_
10-24	1884-1888	they	_
10-25	1889-1893	were	_
10-26	1894-1904	identified	_
10-27	1905-1914	according	_
10-28	1915-1917	to	_
10-29	1918-1921	the	_
10-30	1922-1928	DSM-IV	_
10-31	1929-1939	diagnostic	_
10-32	1940-1948	criteria	_
10-33	1949-1951	by	_
10-34	1952-1961	qualified	_
10-35	1962-1975	psychiatrists	_
10-36	1976-1978	at	_
10-37	1979-1982	the	_
10-38	1983-1989	Taipei	_
10-39	1990-1998	Veterans	_
10-40	1999-2006	General	_
10-41	2007-2015	Hospital	_
10-42	2016-2017	.	_

Text=Exclusion criteria included the presence of DSM-IV Axis I diagnoses of other disorders such as bipolar disorder, history of any substance dependence or history of clinically significant head trauma.
11-1	2018-2027	Exclusion	_
11-2	2028-2036	criteria	_
11-3	2037-2045	included	_
11-4	2046-2049	the	_
11-5	2050-2058	presence	_
11-6	2059-2061	of	_
11-7	2062-2068	DSM-IV	_
11-8	2069-2073	Axis	_
11-9	2074-2075	I	_
11-10	2076-2085	diagnoses	_
11-11	2086-2088	of	_
11-12	2089-2094	other	_
11-13	2095-2104	disorders	_
11-14	2105-2109	such	_
11-15	2110-2112	as	_
11-16	2113-2120	bipolar	_
11-17	2121-2129	disorder	_
11-18	2130-2131	,	_
11-19	2132-2139	history	_
11-20	2140-2142	of	_
11-21	2143-2146	any	_
11-22	2147-2156	substance	_
11-23	2157-2167	dependence	_
11-24	2168-2170	or	_
11-25	2171-2178	history	_
11-26	2179-2181	of	_
11-27	2182-2192	clinically	_
11-28	2193-2204	significant	_
11-29	2205-2209	head	_
11-30	2210-2216	trauma	_
11-31	2217-2218	.	_

Text=Illness durations ranged from several months to 52 years (mean±SD: 17.86±11.1 years).
12-1	2219-2226	Illness	_
12-2	2227-2236	durations	_
12-3	2237-2243	ranged	_
12-4	2244-2248	from	_
12-5	2249-2256	several	_
12-6	2257-2263	months	_
12-7	2264-2266	to	_
12-8	2267-2269	52	_
12-9	2270-2275	years	_
12-10	2276-2277	(	_
12-11	2278-2285	mean±SD	_
12-12	2286-2287	:	_
12-13	2288-2298	17.86±11.1	_
12-14	2299-2304	years	_
12-15	2305-2306	)	_
12-16	2307-2308	.	_

Text=All patients were being treated with a range of antipsychotics.
13-1	2309-2312	All	_
13-2	2313-2321	patients	_
13-3	2322-2326	were	_
13-4	2327-2332	being	_
13-5	2333-2340	treated	_
13-6	2341-2345	with	_
13-7	2346-2347	a	_
13-8	2348-2353	range	_
13-9	2354-2356	of	_
13-10	2357-2371	antipsychotics	_
13-11	2372-2373	.	_

Text=Their average age was 44.99±11.5years and they had a mean education duration of 12.33±3.66 years.
14-1	2374-2379	Their	_
14-2	2380-2387	average	_
14-3	2388-2391	age	_
14-4	2392-2395	was	_
14-5	2396-2411	44.99±11.5years	_
14-6	2412-2415	and	_
14-7	2416-2420	they	_
14-8	2421-2424	had	_
14-9	2425-2426	a	_
14-10	2427-2431	mean	_
14-11	2432-2441	education	_
14-12	2442-2450	duration	_
14-13	2451-2453	of	_
14-14	2454-2464	12.33±3.66	_
14-15	2465-2470	years	_
14-16	2471-2472	.	_

Text=Symptom severity was measured using the Positive and Negative Syndrome Scale (PANSS) assessment which was given to all schizophrenic participants either one week before the MRI scan or one week after it.
15-1	2473-2480	Symptom	_
15-2	2481-2489	severity	_
15-3	2490-2493	was	_
15-4	2494-2502	measured	_
15-5	2503-2508	using	_
15-6	2509-2512	the	_
15-7	2513-2521	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-8	2522-2525	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-9	2526-2534	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-10	2535-2543	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-11	2544-2549	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-12	2550-2551	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-13	2552-2557	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-14	2558-2559	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
15-15	2560-2570	assessment	_
15-16	2571-2576	which	_
15-17	2577-2580	was	_
15-18	2581-2586	given	_
15-19	2587-2589	to	_
15-20	2590-2593	all	_
15-21	2594-2607	schizophrenic	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
15-22	2608-2620	participants	_
15-23	2621-2627	either	_
15-24	2628-2631	one	_
15-25	2632-2636	week	_
15-26	2637-2643	before	_
15-27	2644-2647	the	_
15-28	2648-2651	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
15-29	2652-2656	scan	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
15-30	2657-2659	or	_
15-31	2660-2663	one	_
15-32	2664-2668	week	_
15-33	2669-2674	after	_
15-34	2675-2677	it	_
15-35	2678-2679	.	_

Text=All patients complete their PANSS assessment as listed in Table 1.
16-1	2680-2683	All	_
16-2	2684-2692	patients	_
16-3	2693-2701	complete	_
16-4	2702-2707	their	_
16-5	2708-2713	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
16-6	2714-2724	assessment	_
16-7	2725-2727	as	_
16-8	2728-2734	listed	_
16-9	2735-2737	in	_
16-10	2738-2743	Table	_
16-11	2744-2745	1	_
16-12	2746-2747	.	_

Text=One hundred sixty eight (72 male and 96 female) healthy control subjects were also recruited.
17-1	2748-2751	One	_
17-2	2752-2759	hundred	_
17-3	2760-2765	sixty	_
17-4	2766-2771	eight	_
17-5	2772-2773	(	_
17-6	2774-2776	72	_
17-7	2777-2781	male	_
17-8	2782-2785	and	_
17-9	2786-2788	96	_
17-10	2789-2795	female	_
17-11	2796-2797	)	_
17-12	2798-2805	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-13	2806-2813	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-14	2814-2822	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-15	2823-2827	were	_
17-16	2828-2832	also	_
17-17	2833-2842	recruited	_
17-18	2843-2844	.	_

Text=Their average age was 43.17±10.8 years, and their mean education duration was 15.8±3.5 years.
18-1	2845-2850	Their	_
18-2	2851-2858	average	_
18-3	2859-2862	age	_
18-4	2863-2866	was	_
18-5	2867-2877	43.17±10.8	_
18-6	2878-2883	years	_
18-7	2884-2885	,	_
18-8	2886-2889	and	_
18-9	2890-2895	their	_
18-10	2896-2900	mean	_
18-11	2901-2910	education	_
18-12	2911-2919	duration	_
18-13	2920-2923	was	_
18-14	2924-2932	15.8±3.5	_
18-15	2933-2938	years	_
18-16	2939-2940	.	_

Text=All of the controls were assessed in accordance with DSM-IV criteria as being free of schizophrenia and other Axis I disorders.
19-1	2941-2944	All	_
19-2	2945-2947	of	_
19-3	2948-2951	the	_
19-4	2952-2960	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-5	2961-2965	were	_
19-6	2966-2974	assessed	_
19-7	2975-2977	in	_
19-8	2978-2988	accordance	_
19-9	2989-2993	with	_
19-10	2994-3000	DSM-IV	_
19-11	3001-3009	criteria	_
19-12	3010-3012	as	_
19-13	3013-3018	being	_
19-14	3019-3023	free	_
19-15	3024-3026	of	_
19-16	3027-3040	schizophrenia	_
19-17	3041-3044	and	_
19-18	3045-3050	other	_
19-19	3051-3055	Axis	_
19-20	3056-3057	I	_
19-21	3058-3067	disorders	_
19-22	3068-3069	.	_

Text=None of them had any neurological diseases or suffered from clinically significant head trauma and none had a history of any substance dependence.
20-1	3070-3074	None	_
20-2	3075-3077	of	_
20-3	3078-3082	them	_
20-4	3083-3086	had	_
20-5	3087-3090	any	_
20-6	3091-3103	neurological	_
20-7	3104-3112	diseases	_
20-8	3113-3115	or	_
20-9	3116-3124	suffered	_
20-10	3125-3129	from	_
20-11	3130-3140	clinically	_
20-12	3141-3152	significant	_
20-13	3153-3157	head	_
20-14	3158-3164	trauma	_
20-15	3165-3168	and	_
20-16	3169-3173	none	_
20-17	3174-3177	had	_
20-18	3178-3179	a	_
20-19	3180-3187	history	_
20-20	3188-3190	of	_
20-21	3191-3194	any	_
20-22	3195-3204	substance	_
20-23	3205-3215	dependence	_
20-24	3216-3217	.	_

Text=The patient and control groups were well matched by gender (χ2 = 1.2, p = 0.73) and age (t = 1.48, p = 0.14) although the controls had a slightly longer education duration (t = -8.8, p <0.001).
21-1	3218-3221	The	_
21-2	3222-3229	patient	_
21-3	3230-3233	and	_
21-4	3234-3241	control	_
21-5	3242-3248	groups	_
21-6	3249-3253	were	_
21-7	3254-3258	well	_
21-8	3259-3266	matched	_
21-9	3267-3269	by	_
21-10	3270-3276	gender	_
21-11	3277-3278	(	_
21-12	3279-3281	χ2	_
21-13	3282-3283	=	_
21-14	3284-3287	1.2	_
21-15	3288-3289	,	_
21-16	3290-3291	p	_
21-17	3292-3293	=	_
21-18	3294-3298	0.73	_
21-19	3299-3300	)	_
21-20	3301-3304	and	_
21-21	3305-3308	age	_
21-22	3309-3310	(	_
21-23	3311-3312	t	_
21-24	3313-3314	=	_
21-25	3315-3319	1.48	_
21-26	3320-3321	,	_
21-27	3322-3323	p	_
21-28	3324-3325	=	_
21-29	3326-3330	0.14	_
21-30	3331-3332	)	_
21-31	3333-3341	although	_
21-32	3342-3345	the	_
21-33	3346-3354	controls	_
21-34	3355-3358	had	_
21-35	3359-3360	a	_
21-36	3361-3369	slightly	_
21-37	3370-3376	longer	_
21-38	3377-3386	education	_
21-39	3387-3395	duration	_
21-40	3396-3397	(	_
21-41	3398-3399	t	_
21-42	3400-3401	=	_
21-43	3402-3406	-8.8	_
21-44	3407-3408	,	_
21-45	3409-3410	p	_
21-46	3411-3412	<	_
21-47	3413-3418	0.001	_
21-48	3419-3420	)	_
21-49	3421-3422	.	_

Text=Patient and healthy control demographics are shown in Table 1.
22-1	3423-3430	Patient	_
22-2	3431-3434	and	_
22-3	3435-3442	healthy	_
22-4	3443-3450	control	_
22-5	3451-3463	demographics	_
22-6	3464-3467	are	_
22-7	3468-3473	shown	_
22-8	3474-3476	in	_
22-9	3477-3482	Table	_
22-10	3483-3484	1	_
22-11	3485-3486	.	_

Text=All of the patients were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, then administered a diagnostic structured Mini- International Neuropsychiatric Interview (MINI), Mini-Mental State Examination (MMSE) Chinese version.
23-1	3487-3490	All	_
23-2	3491-3493	of	_
23-3	3494-3497	the	_
23-4	3498-3506	patients	_
23-5	3507-3511	were	_
23-6	3512-3521	diagnosed	_
23-7	3522-3531	according	_
23-8	3532-3534	to	_
23-9	3535-3538	the	_
23-10	3539-3549	Diagnostic	_
23-11	3550-3553	and	_
23-12	3554-3565	Statistical	_
23-13	3566-3572	Manual	_
23-14	3573-3575	of	_
23-15	3576-3582	Mental	_
23-16	3583-3595	Disorders-IV	_
23-17	3596-3604	criteria	_
23-18	3605-3606	,	_
23-19	3607-3611	then	_
23-20	3612-3624	administered	_
23-21	3625-3626	a	_
23-22	3627-3637	diagnostic	_
23-23	3638-3648	structured	_
23-24	3649-3654	Mini-	_
23-25	3655-3668	International	_
23-26	3669-3685	Neuropsychiatric	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
23-27	3686-3695	Interview	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
23-28	3696-3697	(	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
23-29	3698-3702	MINI	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
23-30	3703-3704	)	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
23-31	3705-3706	,	_
23-32	3707-3718	Mini-Mental	http://maven.renci.org/NeuroBridge/neurobridge#ModifiedMiniMentalState
23-33	3719-3724	State	http://maven.renci.org/NeuroBridge/neurobridge#ModifiedMiniMentalState
23-34	3725-3736	Examination	http://maven.renci.org/NeuroBridge/neurobridge#ModifiedMiniMentalState
23-35	3737-3738	(	http://maven.renci.org/NeuroBridge/neurobridge#ModifiedMiniMentalState
23-36	3739-3743	MMSE	http://maven.renci.org/NeuroBridge/neurobridge#ModifiedMiniMentalState
23-37	3744-3745	)	_
23-38	3746-3753	Chinese	_
23-39	3754-3761	version	_
23-40	3762-3763	.	_

Text=The cognitive functioning of the participants was evaluated using the MMSE for general cognitive status and the Wechsler Digit Span subtest for verbal working memory abilities.
24-1	3764-3767	The	_
24-2	3768-3777	cognitive	_
24-3	3778-3789	functioning	_
24-4	3790-3792	of	_
24-5	3793-3796	the	_
24-6	3797-3809	participants	_
24-7	3810-3813	was	_
24-8	3814-3823	evaluated	_
24-9	3824-3829	using	_
24-10	3830-3833	the	_
24-11	3834-3838	MMSE	http://maven.renci.org/NeuroBridge/neurobridge#Thing
24-12	3839-3842	for	_
24-13	3843-3850	general	_
24-14	3851-3860	cognitive	_
24-15	3861-3867	status	_
24-16	3868-3871	and	_
24-17	3872-3875	the	_
24-18	3876-3884	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-19	3885-3890	Digit	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-20	3891-3895	Span	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-21	3896-3903	subtest	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-22	3904-3907	for	_
24-23	3908-3914	verbal	_
24-24	3915-3922	working	_
24-25	3923-3929	memory	_
24-26	3930-3939	abilities	_
24-27	3940-3941	.	_

Text=All participants exhibited sufficient visual and auditory acuity to undergo cognitive testing.
25-1	3942-3945	All	_
25-2	3946-3958	participants	_
25-3	3959-3968	exhibited	_
25-4	3969-3979	sufficient	_
25-5	3980-3986	visual	_
25-6	3987-3990	and	_
25-7	3991-3999	auditory	_
25-8	4000-4006	acuity	_
25-9	4007-4009	to	_
25-10	4010-4017	undergo	_
25-11	4018-4027	cognitive	_
25-12	4028-4035	testing	_
25-13	4036-4037	.	_

Text=This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Taipei Veterans General Hospital.
26-1	4038-4042	This	_
26-2	4043-4048	study	_
26-3	4049-4052	was	_
26-4	4053-4062	conducted	_
26-5	4063-4065	in	_
26-6	4066-4076	accordance	_
26-7	4077-4081	with	_
26-8	4082-4085	the	_
26-9	4086-4097	Declaration	_
26-10	4098-4100	of	_
26-11	4101-4109	Helsinki	_
26-12	4110-4113	and	_
26-13	4114-4122	approved	_
26-14	4123-4125	by	_
26-15	4126-4129	the	_
26-16	4130-4143	Institutional	_
26-17	4144-4150	Review	_
26-18	4151-4156	Board	_
26-19	4157-4159	of	_
26-20	4160-4166	Taipei	_
26-21	4167-4175	Veterans	_
26-22	4176-4183	General	_
26-23	4184-4192	Hospital	_
26-24	4193-4194	.	_

Text=Written informed consent was obtained from all participants ensuring adequate understanding of the study.
27-1	4195-4202	Written	_
27-2	4203-4211	informed	_
27-3	4212-4219	consent	_
27-4	4220-4223	was	_
27-5	4224-4232	obtained	_
27-6	4233-4237	from	_
27-7	4238-4241	all	_
27-8	4242-4254	participants	_
27-9	4255-4263	ensuring	_
27-10	4264-4272	adequate	_
27-11	4273-4286	understanding	_
27-12	4287-4289	of	_
27-13	4290-4293	the	_
27-14	4294-4299	study	_
27-15	4300-4301	.	_

Text=Any participants with the presence of possible dementia or illiteracy were excluded.
28-1	4302-4305	Any	_
28-2	4306-4318	participants	_
28-3	4319-4323	with	_
28-4	4324-4327	the	_
28-5	4328-4336	presence	_
28-6	4337-4339	of	_
28-7	4340-4348	possible	_
28-8	4349-4357	dementia	_
28-9	4358-4360	or	_
28-10	4361-4371	illiteracy	_
28-11	4372-4376	were	_
28-12	4377-4385	excluded	_
28-13	4386-4387	.	_

Text=Imaging acquisitions and data preprocessing Imaging parameters All images were acquired using a 3T MR system (Siemens Magnetom Tim Trio, Erlangen, German) at National Yang-Ming University, equipped with a high-resolution 12-channel head array coil.
29-1	4388-4395	Imaging	_
29-2	4396-4408	acquisitions	_
29-3	4409-4412	and	_
29-4	4413-4417	data	_
29-5	4418-4431	preprocessing	_
29-6	4432-4439	Imaging	_
29-7	4440-4450	parameters	_
29-8	4451-4454	All	_
29-9	4455-4461	images	_
29-10	4462-4466	were	_
29-11	4467-4475	acquired	_
29-12	4476-4481	using	_
29-13	4482-4483	a	_
29-14	4484-4486	3T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
29-15	4487-4489	MR	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
29-16	4490-4496	system	_
29-17	4497-4498	(	_
29-18	4499-4506	Siemens	_
29-19	4507-4515	Magnetom	_
29-20	4516-4519	Tim	_
29-21	4520-4524	Trio	_
29-22	4525-4526	,	_
29-23	4527-4535	Erlangen	_
29-24	4536-4537	,	_
29-25	4538-4544	German	_
29-26	4545-4546	)	_
29-27	4547-4549	at	_
29-28	4550-4558	National	_
29-29	4559-4568	Yang-Ming	_
29-30	4569-4579	University	_
29-31	4580-4581	,	_
29-32	4582-4590	equipped	_
29-33	4591-4595	with	_
29-34	4596-4597	a	_
29-35	4598-4613	high-resolution	_
29-36	4614-4624	12-channel	_
29-37	4625-4629	head	_
29-38	4630-4635	array	_
29-39	4636-4640	coil	_
29-40	4641-4642	.	_

Text=To minimize the head motion during the scan, each subject ’ s head was immobilized with cushions inside the coil during the scan.
30-1	4643-4645	To	_
30-2	4646-4654	minimize	_
30-3	4655-4658	the	_
30-4	4659-4663	head	_
30-5	4664-4670	motion	_
30-6	4671-4677	during	_
30-7	4678-4681	the	_
30-8	4682-4686	scan	_
30-9	4687-4688	,	_
30-10	4689-4693	each	_
30-11	4694-4701	subject	_
30-12	4702-4703	’	_
30-13	4704-4705	s	_
30-14	4706-4710	head	_
30-15	4711-4714	was	_
30-16	4715-4726	immobilized	_
30-17	4727-4731	with	_
30-18	4732-4740	cushions	_
30-19	4741-4747	inside	_
30-20	4748-4751	the	_
30-21	4752-4756	coil	_
30-22	4757-4763	during	_
30-23	4764-4767	the	_
30-24	4768-4772	scan	_
30-25	4773-4774	.	_

Text=A high-resolution anatomical T1-weighted image was acquired with sagittal 3D magnetization-prepared rapid gradient echo (MPRAGE) sequence: repetition time (TR) = 3500 ms, echo time (TE) = 3.5 ms, inversion time = 1100 ms, flip angle = 7°, field of view (FOV) = 256 × 256 mm2, 192 slices, slice thickness = 1 mm, voxel size = 1×1×1 mm3.
31-1	4775-4776	A	_
31-2	4777-4792	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
31-3	4793-4803	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
31-4	4804-4815	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
31-5	4816-4821	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
31-6	4822-4825	was	_
31-7	4826-4834	acquired	_
31-8	4835-4839	with	_
31-9	4840-4848	sagittal	_
31-10	4849-4851	3D	_
31-11	4852-4874	magnetization-prepared	_
31-12	4875-4880	rapid	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-13	4881-4889	gradient	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-14	4890-4894	echo	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-15	4895-4896	(	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-16	4897-4903	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-17	4904-4905	)	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-18	4906-4914	sequence	_
31-19	4915-4916	:	_
31-20	4917-4927	repetition	_
31-21	4928-4932	time	_
31-22	4933-4934	(	_
31-23	4935-4937	TR	_
31-24	4938-4939	)	_
31-25	4940-4941	=	_
31-26	4942-4946	3500	_
31-27	4947-4949	ms	_
31-28	4950-4951	,	_
31-29	4952-4956	echo	_
31-30	4957-4961	time	_
31-31	4962-4963	(	_
31-32	4964-4966	TE	_
31-33	4967-4968	)	_
31-34	4969-4970	=	_
31-35	4971-4974	3.5	_
31-36	4975-4977	ms	_
31-37	4978-4979	,	_
31-38	4980-4989	inversion	_
31-39	4990-4994	time	_
31-40	4995-4996	=	_
31-41	4997-5001	1100	_
31-42	5002-5004	ms	_
31-43	5005-5006	,	_
31-44	5007-5011	flip	_
31-45	5012-5017	angle	_
31-46	5018-5019	=	_
31-47	5020-5022	7°	_
31-48	5023-5024	,	_
31-49	5025-5030	field	_
31-50	5031-5033	of	_
31-51	5034-5038	view	_
31-52	5039-5040	(	_
31-53	5041-5044	FOV	_
31-54	5045-5046	)	_
31-55	5047-5048	=	_
31-56	5049-5052	256	_
31-57	5053-5054	×	_
31-58	5055-5058	256	_
31-59	5059-5062	mm2	_
31-60	5063-5064	,	_
31-61	5065-5068	192	_
31-62	5069-5075	slices	_
31-63	5076-5077	,	_
31-64	5078-5083	slice	_
31-65	5084-5093	thickness	_
31-66	5094-5095	=	_
31-67	5096-5097	1	_
31-68	5098-5100	mm	_
31-69	5101-5102	,	_
31-70	5103-5108	voxel	_
31-71	5109-5113	size	_
31-72	5114-5115	=	_
31-73	5116-5121	1×1×1	_
31-74	5122-5125	mm3	_
31-75	5126-5127	.	_

Text=The diffusion images gradient encoding schemes include 30 non-collinear directions (according to the minimal energy arrangement of electron distribution (http: //www2.research.att.com/~njas/electrons/dim3) with b-value 1000 s/mm2, number of excitations: 3) and 3 non-diffusion weighted image volume.
32-1	5128-5131	The	_
32-2	5132-5141	diffusion	_
32-3	5142-5148	images	_
32-4	5149-5157	gradient	_
32-5	5158-5166	encoding	_
32-6	5167-5174	schemes	_
32-7	5175-5182	include	_
32-8	5183-5185	30	_
32-9	5186-5199	non-collinear	_
32-10	5200-5210	directions	_
32-11	5211-5212	(	_
32-12	5213-5222	according	_
32-13	5223-5225	to	_
32-14	5226-5229	the	_
32-15	5230-5237	minimal	_
32-16	5238-5244	energy	_
32-17	5245-5256	arrangement	_
32-18	5257-5259	of	_
32-19	5260-5268	electron	_
32-20	5269-5281	distribution	_
32-21	5282-5283	(	_
32-22	5284-5288	http	_
32-23	5289-5290	:	_
32-24	5291-5335	//www2.research.att.com/~njas/electrons/dim3	_
32-25	5336-5337	)	_
32-26	5338-5342	with	_
32-27	5343-5350	b-value	_
32-28	5351-5355	1000	_
32-29	5356-5361	s/mm2	_
32-30	5362-5363	,	_
32-31	5364-5370	number	_
32-32	5371-5373	of	_
32-33	5374-5385	excitations	_
32-34	5386-5387	:	_
32-35	5388-5389	3	_
32-36	5390-5391	)	_
32-37	5392-5395	and	_
32-38	5396-5397	3	_
32-39	5398-5411	non-diffusion	_
32-40	5412-5420	weighted	_
32-41	5421-5426	image	_
32-42	5427-5433	volume	_
32-43	5434-5435	.	_

Text=With the consideration of total brain coverage, each volume consisted of 70 contiguous axial slice (thickness: 2 mm) acquired using a single shot spin-echo planar imaging (EPI) sequence (TR: 11,000ms, TE: 104ms, NEX: 6, Matrix size: 128×128, voxel size: 2×2×2 mm3, matrix size: 128×128).
33-1	5436-5440	With	_
33-2	5441-5444	the	_
33-3	5445-5458	consideration	_
33-4	5459-5461	of	_
33-5	5462-5467	total	_
33-6	5468-5473	brain	_
33-7	5474-5482	coverage	_
33-8	5483-5484	,	_
33-9	5485-5489	each	_
33-10	5490-5496	volume	_
33-11	5497-5506	consisted	_
33-12	5507-5509	of	_
33-13	5510-5512	70	_
33-14	5513-5523	contiguous	_
33-15	5524-5529	axial	_
33-16	5530-5535	slice	_
33-17	5536-5537	(	_
33-18	5538-5547	thickness	_
33-19	5548-5549	:	_
33-20	5550-5551	2	_
33-21	5552-5554	mm	_
33-22	5555-5556	)	_
33-23	5557-5565	acquired	_
33-24	5566-5571	using	_
33-25	5572-5573	a	_
33-26	5574-5580	single	_
33-27	5581-5585	shot	_
33-28	5586-5595	spin-echo	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-29	5596-5602	planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-30	5603-5610	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-31	5611-5612	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-32	5613-5616	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-33	5617-5618	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
33-34	5619-5627	sequence	_
33-35	5628-5629	(	_
33-36	5630-5632	TR	_
33-37	5633-5634	:	_
33-38	5635-5643	11,000ms	_
33-39	5644-5645	,	_
33-40	5646-5648	TE	_
33-41	5649-5650	:	_
33-42	5651-5656	104ms	_
33-43	5657-5658	,	_
33-44	5659-5662	NEX	_
33-45	5663-5664	:	_
33-46	5665-5666	6	_
33-47	5667-5668	,	_
33-48	5669-5675	Matrix	_
33-49	5676-5680	size	_
33-50	5681-5682	:	_
33-51	5683-5690	128×128	_
33-52	5691-5692	,	_
33-53	5693-5698	voxel	_
33-54	5699-5703	size	_
33-55	5704-5705	:	_
33-56	5706-5711	2×2×2	_
33-57	5712-5715	mm3	_
33-58	5716-5717	,	_
33-59	5718-5724	matrix	_
33-60	5725-5729	size	_
33-61	5730-5731	:	_
33-62	5732-5739	128×128	_
33-63	5740-5741	)	_
33-64	5742-5743	.	_

Text=For resting state fMRI: T2-weighted images with BOLD contrast were measured using a gradient echo- planar imaging (EPI) sequence (repetition time, TR: 2,500 ms, echo time, TE: 27 ms, field of view, FoV: 220 mm, flip angle: 77 degree, matrix size: 64×64, and voxel size: 3.44×3.44×3.40 mm3), participants were instructed to relax with their eyes closed, without falling asleep during the total 8min scan time.
34-1	5744-5747	For	_
34-2	5748-5755	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
34-3	5756-5761	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
34-4	5762-5766	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
34-5	5767-5768	:	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
34-6	5769-5780	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
34-7	5781-5787	images	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
34-8	5788-5792	with	_
34-9	5793-5797	BOLD	_
34-10	5798-5806	contrast	_
34-11	5807-5811	were	_
34-12	5812-5820	measured	_
34-13	5821-5826	using	_
34-14	5827-5828	a	_
34-15	5829-5837	gradient	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-16	5838-5843	echo-	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-17	5844-5850	planar	_
34-18	5851-5858	imaging	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
34-19	5859-5860	(	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
34-20	5861-5864	EPI	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
34-21	5865-5866	)	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
34-22	5867-5875	sequence	_
34-23	5876-5877	(	_
34-24	5878-5888	repetition	_
34-25	5889-5893	time	_
34-26	5894-5895	,	_
34-27	5896-5898	TR	_
34-28	5899-5900	:	_
34-29	5901-5906	2,500	_
34-30	5907-5909	ms	_
34-31	5910-5911	,	_
34-32	5912-5916	echo	_
34-33	5917-5921	time	_
34-34	5922-5923	,	_
34-35	5924-5926	TE	_
34-36	5927-5928	:	_
34-37	5929-5931	27	_
34-38	5932-5934	ms	_
34-39	5935-5936	,	_
34-40	5937-5942	field	_
34-41	5943-5945	of	_
34-42	5946-5950	view	_
34-43	5951-5952	,	_
34-44	5953-5956	FoV	_
34-45	5957-5958	:	_
34-46	5959-5962	220	_
34-47	5963-5965	mm	_
34-48	5966-5967	,	_
34-49	5968-5972	flip	_
34-50	5973-5978	angle	_
34-51	5979-5980	:	_
34-52	5981-5983	77	_
34-53	5984-5990	degree	_
34-54	5991-5992	,	_
34-55	5993-5999	matrix	_
34-56	6000-6004	size	_
34-57	6005-6006	:	_
34-58	6007-6012	64×64	_
34-59	6013-6014	,	_
34-60	6015-6018	and	_
34-61	6019-6024	voxel	_
34-62	6025-6029	size	_
34-63	6030-6031	:	_
34-64	6032-6046	3.44×3.44×3.40	_
34-65	6047-6050	mm3	_
34-66	6051-6052	)	_
34-67	6053-6054	,	_
34-68	6055-6067	participants	_
34-69	6068-6072	were	_
34-70	6073-6083	instructed	_
34-71	6084-6086	to	_
34-72	6087-6092	relax	_
34-73	6093-6097	with	_
34-74	6098-6103	their	_
34-75	6104-6108	eyes	_
34-76	6109-6115	closed	_
34-77	6116-6117	,	_
34-78	6118-6125	without	_
34-79	6126-6133	falling	_
34-80	6134-6140	asleep	_
34-81	6141-6147	during	_
34-82	6148-6151	the	_
34-83	6152-6157	total	_
34-84	6158-6162	8min	_
34-85	6163-6167	scan	_
34-86	6168-6172	time	_
34-87	6173-6174	.	_

Text=For each run, 200 EPI volume images were acquired along the anterior and posterior commissure (AC–PC) plane.
35-1	6175-6178	For	_
35-2	6179-6183	each	_
35-3	6184-6187	run	_
35-4	6188-6189	,	_
35-5	6190-6193	200	_
35-6	6194-6197	EPI	_
35-7	6198-6204	volume	_
35-8	6205-6211	images	_
35-9	6212-6216	were	_
35-10	6217-6225	acquired	_
35-11	6226-6231	along	_
35-12	6232-6235	the	_
35-13	6236-6244	anterior	_
35-14	6245-6248	and	_
35-15	6249-6258	posterior	_
35-16	6259-6269	commissure	_
35-17	6270-6271	(	_
35-18	6272-6277	AC–PC	_
35-19	6278-6279	)	_
35-20	6280-6285	plane	_
35-21	6286-6287	.	_

Text=After the resting state experiment, participants were asked whether they fell asleep during the resting state scan session, and the participants were rescanned if they slept during the resting state scan.
36-1	6288-6293	After	_
36-2	6294-6297	the	_
36-3	6298-6305	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-4	6306-6311	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-5	6312-6322	experiment	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-6	6323-6324	,	_
36-7	6325-6337	participants	_
36-8	6338-6342	were	_
36-9	6343-6348	asked	_
36-10	6349-6356	whether	_
36-11	6357-6361	they	_
36-12	6362-6366	fell	_
36-13	6367-6373	asleep	_
36-14	6374-6380	during	_
36-15	6381-6384	the	_
36-16	6385-6392	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-17	6393-6398	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-18	6399-6403	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-19	6404-6411	session	_
36-20	6412-6413	,	_
36-21	6414-6417	and	_
36-22	6418-6421	the	_
36-23	6422-6434	participants	_
36-24	6435-6439	were	_
36-25	6440-6449	rescanned	_
36-26	6450-6452	if	_
36-27	6453-6457	they	_
36-28	6458-6463	slept	_
36-29	6464-6470	during	_
36-30	6471-6474	the	_
36-31	6475-6482	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-32	6483-6488	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-33	6489-6493	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
36-34	6494-6495	.	_

Text=fMRI preprocessing fMRI data preprocessing was then conducted by SPM8 (University College London, UK; http: //www.fil.ion.ucl.ac.uk/spm) and DPARSF (Data Processing Assistant for resting-state fMRI).
37-1	6496-6500	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-2	6501-6514	preprocessing	_
37-3	6515-6519	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-4	6520-6524	data	_
37-5	6525-6538	preprocessing	_
37-6	6539-6542	was	_
37-7	6543-6547	then	_
37-8	6548-6557	conducted	_
37-9	6558-6560	by	_
37-10	6561-6565	SPM8	_
37-11	6566-6567	(	_
37-12	6568-6578	University	_
37-13	6579-6586	College	_
37-14	6587-6593	London	_
37-15	6594-6595	,	_
37-16	6596-6598	UK	_
37-17	6599-6600	;	_
37-18	6601-6605	http	_
37-19	6606-6607	:	_
37-20	6608-6635	//www.fil.ion.ucl.ac.uk/spm	_
37-21	6636-6637	)	_
37-22	6638-6641	and	_
37-23	6642-6648	DPARSF	_
37-24	6649-6650	(	_
37-25	6651-6655	Data	_
37-26	6656-6666	Processing	_
37-27	6667-6676	Assistant	_
37-28	6677-6680	for	_
37-29	6681-6694	resting-state	_
37-30	6695-6699	fMRI	_
37-31	6700-6701	)	_
37-32	6702-6703	.	_

Text=Briefly, the remaining functional scans were first corrected for within-scan acquisition time differences between slices, and then realigned to the middle volume to correct for interscan head motions.
38-1	6704-6711	Briefly	_
38-2	6712-6713	,	_
38-3	6714-6717	the	_
38-4	6718-6727	remaining	_
38-5	6728-6738	functional	_
38-6	6739-6744	scans	_
38-7	6745-6749	were	_
38-8	6750-6755	first	_
38-9	6756-6765	corrected	_
38-10	6766-6769	for	_
38-11	6770-6781	within-scan	_
38-12	6782-6793	acquisition	_
38-13	6794-6798	time	_
38-14	6799-6810	differences	_
38-15	6811-6818	between	_
38-16	6819-6825	slices	_
38-17	6826-6827	,	_
38-18	6828-6831	and	_
38-19	6832-6836	then	_
38-20	6837-6846	realigned	_
38-21	6847-6849	to	_
38-22	6850-6853	the	_
38-23	6854-6860	middle	_
38-24	6861-6867	volume	_
38-25	6868-6870	to	_
38-26	6871-6878	correct	_
38-27	6879-6882	for	_
38-28	6883-6892	interscan	_
38-29	6893-6897	head	_
38-30	6898-6905	motions	_
38-31	6906-6907	.	_

Text=Subsequently, the functional scans were spatially normalized to a standard template (Montreal Neurological Institute) and resampled to 3×3×3mm3.
39-1	6908-6920	Subsequently	_
39-2	6921-6922	,	_
39-3	6923-6926	the	_
39-4	6927-6937	functional	_
39-5	6938-6943	scans	_
39-6	6944-6948	were	_
39-7	6949-6958	spatially	_
39-8	6959-6969	normalized	_
39-9	6970-6972	to	_
39-10	6973-6974	a	_
39-11	6975-6983	standard	_
39-12	6984-6992	template	_
39-13	6993-6994	(	_
39-14	6995-7003	Montreal	_
39-15	7004-7016	Neurological	_
39-16	7017-7026	Institute	_
39-17	7027-7028	)	_
39-18	7029-7032	and	_
39-19	7033-7042	resampled	_
39-20	7043-7045	to	_
39-21	7046-7054	3×3×3mm3	_
39-22	7055-7056	.	_

Text=After normalization, the Blood Oxygenation Level Dependent (BOLD) signal of each voxel was first detrended to abandon linear trend and then passed through a bandpass filter (0.01–0.08 Hz) to reduce low-frequency drift and high-frequency physiological noise.
40-1	7057-7062	After	_
40-2	7063-7076	normalization	_
40-3	7077-7078	,	_
40-4	7079-7082	the	_
40-5	7083-7088	Blood	_
40-6	7089-7100	Oxygenation	_
40-7	7101-7106	Level	_
40-8	7107-7116	Dependent	_
40-9	7117-7118	(	_
40-10	7119-7123	BOLD	_
40-11	7124-7125	)	_
40-12	7126-7132	signal	_
40-13	7133-7135	of	_
40-14	7136-7140	each	_
40-15	7141-7146	voxel	_
40-16	7147-7150	was	_
40-17	7151-7156	first	_
40-18	7157-7166	detrended	_
40-19	7167-7169	to	_
40-20	7170-7177	abandon	_
40-21	7178-7184	linear	_
40-22	7185-7190	trend	_
40-23	7191-7194	and	_
40-24	7195-7199	then	_
40-25	7200-7206	passed	_
40-26	7207-7214	through	_
40-27	7215-7216	a	_
40-28	7217-7225	bandpass	_
40-29	7226-7232	filter	_
40-30	7233-7234	(	_
40-31	7235-7244	0.01–0.08	_
40-32	7245-7247	Hz	_
40-33	7248-7249	)	_
40-34	7250-7252	to	_
40-35	7253-7259	reduce	_
40-36	7260-7273	low-frequency	_
40-37	7274-7279	drift	_
40-38	7280-7283	and	_
40-39	7284-7298	high-frequency	_
40-40	7299-7312	physiological	_
40-41	7313-7318	noise	_
40-42	7319-7320	.	_

Text=Finally, nuisance covariates including head motion parameters, global mean signals, white matter signals and cerebrospinal fluid signals were regressed out from the Blood Oxygenation Level Dependent signals.
41-1	7321-7328	Finally	_
41-2	7329-7330	,	_
41-3	7331-7339	nuisance	_
41-4	7340-7350	covariates	_
41-5	7351-7360	including	_
41-6	7361-7365	head	_
41-7	7366-7372	motion	_
41-8	7373-7383	parameters	_
41-9	7384-7385	,	_
41-10	7386-7392	global	_
41-11	7393-7397	mean	_
41-12	7398-7405	signals	_
41-13	7406-7407	,	_
41-14	7408-7413	white	_
41-15	7414-7420	matter	_
41-16	7421-7428	signals	_
41-17	7429-7432	and	_
41-18	7433-7446	cerebrospinal	_
41-19	7447-7452	fluid	_
41-20	7453-7460	signals	_
41-21	7461-7465	were	_
41-22	7466-7475	regressed	_
41-23	7476-7479	out	_
41-24	7480-7484	from	_
41-25	7485-7488	the	_
41-26	7489-7494	Blood	_
41-27	7495-7506	Oxygenation	_
41-28	7507-7512	Level	_
41-29	7513-7522	Dependent	_
41-30	7523-7530	signals	_
41-31	7531-7532	.	_

Text=sMRI preprocessing All T1-weighted structural data were pre-processed using the Diffeomorphic Anatomical Registration using Exponentiated Lie algebra (DARTEL) toolbox in SPM8 software (http: //www.fil.ion.ucl.ac.uk/spm) running under Matlab (MathWorks, USA).
42-1	7533-7537	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
42-2	7538-7551	preprocessing	_
42-3	7552-7555	All	_
42-4	7556-7567	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
42-5	7568-7578	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
42-6	7579-7583	data	_
42-7	7584-7588	were	_
42-8	7589-7602	pre-processed	_
42-9	7603-7608	using	_
42-10	7609-7612	the	_
42-11	7613-7626	Diffeomorphic	_
42-12	7627-7637	Anatomical	_
42-13	7638-7650	Registration	_
42-14	7651-7656	using	_
42-15	7657-7670	Exponentiated	_
42-16	7671-7674	Lie	_
42-17	7675-7682	algebra	_
42-18	7683-7684	(	_
42-19	7685-7691	DARTEL	_
42-20	7692-7693	)	_
42-21	7694-7701	toolbox	_
42-22	7702-7704	in	_
42-23	7705-7709	SPM8	_
42-24	7710-7718	software	_
42-25	7719-7720	(	_
42-26	7721-7725	http	_
42-27	7726-7727	:	_
42-28	7728-7755	//www.fil.ion.ucl.ac.uk/spm	_
42-29	7756-7757	)	_
42-30	7758-7765	running	_
42-31	7766-7771	under	_
42-32	7772-7778	Matlab	_
42-33	7779-7780	(	_
42-34	7781-7790	MathWorks	_
42-35	7791-7792	,	_
42-36	7793-7796	USA	_
42-37	7797-7798	)	_
42-38	7799-7800	.	_

Text=This procedure involves the creation of a study-specific template and the segmentation of each individual image using said template, with the aim of maximizing accuracy and sensitivity.
43-1	7801-7805	This	_
43-2	7806-7815	procedure	_
43-3	7816-7824	involves	_
43-4	7825-7828	the	_
43-5	7829-7837	creation	_
43-6	7838-7840	of	_
43-7	7841-7842	a	_
43-8	7843-7857	study-specific	_
43-9	7858-7866	template	_
43-10	7867-7870	and	_
43-11	7871-7874	the	_
43-12	7875-7887	segmentation	_
43-13	7888-7890	of	_
43-14	7891-7895	each	_
43-15	7896-7906	individual	_
43-16	7907-7912	image	_
43-17	7913-7918	using	_
43-18	7919-7923	said	_
43-19	7924-7932	template	_
43-20	7933-7934	,	_
43-21	7935-7939	with	_
43-22	7940-7943	the	_
43-23	7944-7947	aim	_
43-24	7948-7950	of	_
43-25	7951-7961	maximizing	_
43-26	7962-7970	accuracy	_
43-27	7971-7974	and	_
43-28	7975-7986	sensitivity	_
43-29	7987-7988	.	_

Text=After modulate normalizing, the images were segmented into gray matter, white matter and the cerebrospinal fluid.
44-1	7989-7994	After	_
44-2	7995-8003	modulate	_
44-3	8004-8015	normalizing	_
44-4	8016-8017	,	_
44-5	8018-8021	the	_
44-6	8022-8028	images	_
44-7	8029-8033	were	_
44-8	8034-8043	segmented	_
44-9	8044-8048	into	_
44-10	8049-8053	gray	_
44-11	8054-8060	matter	_
44-12	8061-8062	,	_
44-13	8063-8068	white	_
44-14	8069-8075	matter	_
44-15	8076-8079	and	_
44-16	8080-8083	the	_
44-17	8084-8097	cerebrospinal	_
44-18	8098-8103	fluid	_
44-19	8104-8105	.	_

Text=These segmented images were smoothed using a 12-mm full width at half maximum (FWHM) Gaussian kernel.
45-1	8106-8111	These	_
45-2	8112-8121	segmented	_
45-3	8122-8128	images	_
45-4	8129-8133	were	_
45-5	8134-8142	smoothed	_
45-6	8143-8148	using	_
45-7	8149-8150	a	_
45-8	8151-8156	12-mm	_
45-9	8157-8161	full	_
45-10	8162-8167	width	_
45-11	8168-8170	at	_
45-12	8171-8175	half	_
45-13	8176-8183	maximum	_
45-14	8184-8185	(	_
45-15	8186-8190	FWHM	_
45-16	8191-8192	)	_
45-17	8193-8201	Gaussian	_
45-18	8202-8208	kernel	_
45-19	8209-8210	.	_

Text=DTI preprocessing Before image data processing, one author (Chu-Chung Huang, an experienced radiological technician) received all of the MRI scans to confirm that the participants were free of any morphological abnormalities and apparent WM lesions.
46-1	8211-8214	DTI	_
46-2	8215-8228	preprocessing	_
46-3	8229-8235	Before	_
46-4	8236-8241	image	_
46-5	8242-8246	data	_
46-6	8247-8257	processing	_
46-7	8258-8259	,	_
46-8	8260-8263	one	_
46-9	8264-8270	author	_
46-10	8271-8272	(	_
46-11	8273-8282	Chu-Chung	_
46-12	8283-8288	Huang	_
46-13	8289-8290	,	_
46-14	8291-8293	an	_
46-15	8294-8305	experienced	_
46-16	8306-8318	radiological	_
46-17	8319-8329	technician	_
46-18	8330-8331	)	_
46-19	8332-8340	received	_
46-20	8341-8344	all	_
46-21	8345-8347	of	_
46-22	8348-8351	the	_
46-23	8352-8355	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
46-24	8356-8361	scans	_
46-25	8362-8364	to	_
46-26	8365-8372	confirm	_
46-27	8373-8377	that	_
46-28	8378-8381	the	_
46-29	8382-8394	participants	_
46-30	8395-8399	were	_
46-31	8400-8404	free	_
46-32	8405-8407	of	_
46-33	8408-8411	any	_
46-34	8412-8425	morphological	_
46-35	8426-8439	abnormalities	_
46-36	8440-8443	and	_
46-37	8444-8452	apparent	_
46-38	8453-8455	WM	_
46-39	8456-8463	lesions	_
46-40	8464-8465	.	_

Text=Eddy current correction and brain tissue extraction of DTI dataset were pre-processed using FSL 5.0.9 (Functional Magnetic Resonance Imaging of the Brain Software Library; http: //www.fmrib.ox.ac.uk/fsl).
47-1	8466-8470	Eddy	_
47-2	8471-8478	current	_
47-3	8479-8489	correction	_
47-4	8490-8493	and	_
47-5	8494-8499	brain	_
47-6	8500-8506	tissue	_
47-7	8507-8517	extraction	_
47-8	8518-8520	of	_
47-9	8521-8524	DTI	_
47-10	8525-8532	dataset	_
47-11	8533-8537	were	_
47-12	8538-8551	pre-processed	_
47-13	8552-8557	using	_
47-14	8558-8561	FSL	_
47-15	8562-8567	5.0.9	_
47-16	8568-8569	(	_
47-17	8570-8580	Functional	_
47-18	8581-8589	Magnetic	_
47-19	8590-8599	Resonance	_
47-20	8600-8607	Imaging	_
47-21	8608-8610	of	_
47-22	8611-8614	the	_
47-23	8615-8620	Brain	_
47-24	8621-8629	Software	_
47-25	8630-8637	Library	_
47-26	8638-8639	;	_
47-27	8640-8644	http	_
47-28	8645-8646	:	_
47-29	8647-8671	//www.fmrib.ox.ac.uk/fsl	_
47-30	8672-8673	)	_
47-31	8674-8675	.	_

Text=Eddy current correction involved registering the diffusion-weighted images to the non-diffusion weighted image through affine transformations.
48-1	8676-8680	Eddy	_
48-2	8681-8688	current	_
48-3	8689-8699	correction	_
48-4	8700-8708	involved	_
48-5	8709-8720	registering	_
48-6	8721-8724	the	_
48-7	8725-8743	diffusion-weighted	_
48-8	8744-8750	images	_
48-9	8751-8753	to	_
48-10	8754-8757	the	_
48-11	8758-8771	non-diffusion	_
48-12	8772-8780	weighted	_
48-13	8781-8786	image	_
48-14	8787-8794	through	_
48-15	8795-8801	affine	_
48-16	8802-8817	transformations	_
48-17	8818-8819	.	_

Text=It was done not only to minimize image distortion derived from eddy currents induced by fast-switching gradient coils, but also to reduce the simple head motion.
49-1	8820-8822	It	_
49-2	8823-8826	was	_
49-3	8827-8831	done	_
49-4	8832-8835	not	_
49-5	8836-8840	only	_
49-6	8841-8843	to	_
49-7	8844-8852	minimize	_
49-8	8853-8858	image	_
49-9	8859-8869	distortion	_
49-10	8870-8877	derived	_
49-11	8878-8882	from	_
49-12	8883-8887	eddy	_
49-13	8888-8896	currents	_
49-14	8897-8904	induced	_
49-15	8905-8907	by	_
49-16	8908-8922	fast-switching	_
49-17	8923-8931	gradient	_
49-18	8932-8937	coils	_
49-19	8938-8939	,	_
49-20	8940-8943	but	_
49-21	8944-8948	also	_
49-22	8949-8951	to	_
49-23	8952-8958	reduce	_
49-24	8959-8962	the	_
49-25	8963-8969	simple	_
49-26	8970-8974	head	_
49-27	8975-8981	motion	_
49-28	8982-8983	.	_

Text=Subsequently, the Brain Extraction Tool (BET) compiled in FSL was applied to remove the non-brain tissue and background noise from the images.
50-1	8984-8996	Subsequently	_
50-2	8997-8998	,	_
50-3	8999-9002	the	_
50-4	9003-9008	Brain	_
50-5	9009-9019	Extraction	_
50-6	9020-9024	Tool	_
50-7	9025-9026	(	_
50-8	9027-9030	BET	_
50-9	9031-9032	)	_
50-10	9033-9041	compiled	_
50-11	9042-9044	in	_
50-12	9045-9048	FSL	_
50-13	9049-9052	was	_
50-14	9053-9060	applied	_
50-15	9061-9063	to	_
50-16	9064-9070	remove	_
50-17	9071-9074	the	_
50-18	9075-9084	non-brain	_
50-19	9085-9091	tissue	_
50-20	9092-9095	and	_
50-21	9096-9106	background	_
50-22	9107-9112	noise	_
50-23	9113-9117	from	_
50-24	9118-9121	the	_
50-25	9122-9128	images	_
50-26	9129-9130	.	_

Text=After DTI preprocessing, parameter maps include FA (relative ratio of axial to radial diffusivities), RD (radial diffusivity, (λ2+λ3) /2 and MD (mean diffusivity, (λ1+λ2+λ3) /3) were calculated by fitting Baser ’ s DTI tensor model at each voxel using in-house software.
51-1	9131-9136	After	_
51-2	9137-9140	DTI	_
51-3	9141-9154	preprocessing	_
51-4	9155-9156	,	_
51-5	9157-9166	parameter	_
51-6	9167-9171	maps	_
51-7	9172-9179	include	_
51-8	9180-9182	FA	_
51-9	9183-9184	(	_
51-10	9185-9193	relative	_
51-11	9194-9199	ratio	_
51-12	9200-9202	of	_
51-13	9203-9208	axial	_
51-14	9209-9211	to	_
51-15	9212-9218	radial	_
51-16	9219-9232	diffusivities	_
51-17	9233-9234	)	_
51-18	9235-9236	,	_
51-19	9237-9239	RD	_
51-20	9240-9241	(	_
51-21	9242-9248	radial	_
51-22	9249-9260	diffusivity	_
51-23	9261-9262	,	_
51-24	9263-9264	(	_
51-25	9265-9270	λ2+λ3	_
51-26	9271-9272	)	_
51-27	9273-9275	/2	_
51-28	9276-9279	and	_
51-29	9280-9282	MD	_
51-30	9283-9284	(	_
51-31	9285-9289	mean	_
51-32	9290-9301	diffusivity	_
51-33	9302-9303	,	_
51-34	9304-9305	(	_
51-35	9306-9314	λ1+λ2+λ3	_
51-36	9315-9316	)	_
51-37	9317-9319	/3	_
51-38	9320-9321	)	_
51-39	9322-9326	were	_
51-40	9327-9337	calculated	_
51-41	9338-9340	by	_
51-42	9341-9348	fitting	_
51-43	9349-9354	Baser	_
51-44	9355-9356	’	_
51-45	9357-9358	s	_
51-46	9359-9362	DTI	_
51-47	9363-9369	tensor	_
51-48	9370-9375	model	_
51-49	9376-9378	at	_
51-50	9379-9383	each	_
51-51	9384-9389	voxel	_
51-52	9390-9395	using	_
51-53	9396-9404	in-house	_
51-54	9405-9413	software	_
51-55	9414-9415	.	_

Text=The definitions of λ1, λ2, λ3 are given in Supplemental Materials.
52-1	9416-9419	The	_
52-2	9420-9431	definitions	_
52-3	9432-9434	of	_
52-4	9435-9437	λ1	_
52-5	9438-9439	,	_
52-6	9440-9442	λ2	_
52-7	9443-9444	,	_
52-8	9445-9447	λ3	_
52-9	9448-9451	are	_
52-10	9452-9457	given	_
52-11	9458-9460	in	_
52-12	9461-9473	Supplemental	_
52-13	9474-9483	Materials	_
52-14	9484-9485	.	_

Text=Construction of multi-index vector for each ROI After preprocessing, each modality is first reduced to a “ feature ” for each subject, which tends to be more tractable than working with the large-scale original data and provides a simpler space to link the data.
53-1	9486-9498	Construction	_
53-2	9499-9501	of	_
53-3	9502-9513	multi-index	_
53-4	9514-9520	vector	_
53-5	9521-9524	for	_
53-6	9525-9529	each	_
53-7	9530-9533	ROI	_
53-8	9534-9539	After	_
53-9	9540-9553	preprocessing	_
53-10	9554-9555	,	_
53-11	9556-9560	each	_
53-12	9561-9569	modality	_
53-13	9570-9572	is	_
53-14	9573-9578	first	_
53-15	9579-9586	reduced	_
53-16	9587-9589	to	_
53-17	9590-9591	a	_
53-18	9592-9593	“	_
53-19	9594-9601	feature	_
53-20	9602-9603	”	_
53-21	9604-9607	for	_
53-22	9608-9612	each	_
53-23	9613-9620	subject	_
53-24	9621-9622	,	_
53-25	9623-9628	which	_
53-26	9629-9634	tends	_
53-27	9635-9637	to	_
53-28	9638-9640	be	_
53-29	9641-9645	more	_
53-30	9646-9655	tractable	_
53-31	9656-9660	than	_
53-32	9661-9668	working	_
53-33	9669-9673	with	_
53-34	9674-9677	the	_
53-35	9678-9689	large-scale	_
53-36	9690-9698	original	_
53-37	9699-9703	data	_
53-38	9704-9707	and	_
53-39	9708-9716	provides	_
53-40	9717-9718	a	_
53-41	9719-9726	simpler	_
53-42	9727-9732	space	_
53-43	9733-9735	to	_
53-44	9736-9740	link	_
53-45	9741-9744	the	_
53-46	9745-9749	data	_
53-47	9750-9751	.	_

Text=In this paper, an automated anatomical labeling atlas was used to parcellate the brain into 90 regions of interest (ROIs) (45 in each hemisphere) and the “ feature ” is obtained for each ROI.
54-1	9752-9754	In	_
54-2	9755-9759	this	_
54-3	9760-9765	paper	_
54-4	9766-9767	,	_
54-5	9768-9770	an	_
54-6	9771-9780	automated	_
54-7	9781-9791	anatomical	_
54-8	9792-9800	labeling	_
54-9	9801-9806	atlas	_
54-10	9807-9810	was	_
54-11	9811-9815	used	_
54-12	9816-9818	to	_
54-13	9819-9829	parcellate	_
54-14	9830-9833	the	_
54-15	9834-9839	brain	_
54-16	9840-9844	into	_
54-17	9845-9847	90	_
54-18	9848-9855	regions	_
54-19	9856-9858	of	_
54-20	9859-9867	interest	_
54-21	9868-9869	(	_
54-22	9870-9874	ROIs	_
54-23	9875-9876	)	_
54-24	9877-9878	(	_
54-25	9879-9881	45	_
54-26	9882-9884	in	_
54-27	9885-9889	each	_
54-28	9890-9900	hemisphere	_
54-29	9901-9902	)	_
54-30	9903-9906	and	_
54-31	9907-9910	the	_
54-32	9911-9912	“	_
54-33	9913-9920	feature	_
54-34	9921-9922	”	_
54-35	9923-9925	is	_
54-36	9926-9934	obtained	_
54-37	9935-9938	for	_
54-38	9939-9943	each	_
54-39	9944-9947	ROI	_
54-40	9948-9949	.	_

Text=The names of the ROIs and their corresponding abbreviations are listed in S1 Table.
55-1	9950-9953	The	_
55-2	9954-9959	names	_
55-3	9960-9962	of	_
55-4	9963-9966	the	_
55-5	9967-9971	ROIs	_
55-6	9972-9975	and	_
55-7	9976-9981	their	_
55-8	9982-9995	corresponding	_
55-9	9996-10009	abbreviations	_
55-10	10010-10013	are	_
55-11	10014-10020	listed	_
55-12	10021-10023	in	_
55-13	10024-10026	S1	_
55-14	10027-10032	Table	_
55-15	10033-10034	.	_

Text=For fMRI, the time series were firstly extracted in each ROI by averaging the signals of all voxels within that region.
56-1	10035-10038	For	_
56-2	10039-10043	fMRI	_
56-3	10044-10045	,	_
56-4	10046-10049	the	_
56-5	10050-10054	time	_
56-6	10055-10061	series	_
56-7	10062-10066	were	_
56-8	10067-10074	firstly	_
56-9	10075-10084	extracted	_
56-10	10085-10087	in	_
56-11	10088-10092	each	_
56-12	10093-10096	ROI	_
56-13	10097-10099	by	_
56-14	10100-10109	averaging	_
56-15	10110-10113	the	_
56-16	10114-10121	signals	_
56-17	10122-10124	of	_
56-18	10125-10128	all	_
56-19	10129-10135	voxels	_
56-20	10136-10142	within	_
56-21	10143-10147	that	_
56-22	10148-10154	region	_
56-23	10155-10156	.	_

Text=Secondly, ordinary Pearson correlation coefficients with all other 89 different ROIs were calculated for each ROI.
57-1	10157-10165	Secondly	_
57-2	10166-10167	,	_
57-3	10168-10176	ordinary	_
57-4	10177-10184	Pearson	_
57-5	10185-10196	correlation	_
57-6	10197-10209	coefficients	_
57-7	10210-10214	with	_
57-8	10215-10218	all	_
57-9	10219-10224	other	_
57-10	10225-10227	89	_
57-11	10228-10237	different	_
57-12	10238-10242	ROIs	_
57-13	10243-10247	were	_
57-14	10248-10258	calculated	_
57-15	10259-10262	for	_
57-16	10263-10267	each	_
57-17	10268-10271	ROI	_
57-18	10272-10273	.	_

Text=A Fisher ’ s r-to-z transformation was utilized to convert each correlation coefficient rij into Zij to improve the normality.
58-1	10274-10275	A	_
58-2	10276-10282	Fisher	_
58-3	10283-10284	’	_
58-4	10285-10286	s	_
58-5	10287-10293	r-to-z	_
58-6	10294-10308	transformation	_
58-7	10309-10312	was	_
58-8	10313-10321	utilized	_
58-9	10322-10324	to	_
58-10	10325-10332	convert	_
58-11	10333-10337	each	_
58-12	10338-10349	correlation	_
58-13	10350-10361	coefficient	_
58-14	10362-10365	rij	_
58-15	10366-10370	into	_
58-16	10371-10374	Zij	_
58-17	10375-10377	to	_
58-18	10378-10385	improve	_
58-19	10386-10389	the	_
58-20	10390-10399	normality	_
58-21	10400-10401	.	_

Text=A vector consisting of all these 89 functional connectivity (FC) coefficients (Zij) was constructed as the functional measure (fMRI) for each ROI.
59-1	10402-10403	A	_
59-2	10404-10410	vector	_
59-3	10411-10421	consisting	_
59-4	10422-10424	of	_
59-5	10425-10428	all	_
59-6	10429-10434	these	_
59-7	10435-10437	89	_
59-8	10438-10448	functional	_
59-9	10449-10461	connectivity	_
59-10	10462-10463	(	_
59-11	10464-10466	FC	_
59-12	10467-10468	)	_
59-13	10469-10481	coefficients	_
59-14	10482-10483	(	_
59-15	10484-10487	Zij	_
59-16	10488-10489	)	_
59-17	10490-10493	was	_
59-18	10494-10505	constructed	_
59-19	10506-10508	as	_
59-20	10509-10512	the	_
59-21	10513-10523	functional	_
59-22	10524-10531	measure	_
59-23	10532-10533	(	_
59-24	10534-10538	fMRI	_
59-25	10539-10540	)	_
59-26	10541-10544	for	_
59-27	10545-10549	each	_
59-28	10550-10553	ROI	_
59-29	10554-10555	.	_

Text=For sMRI, the volume of grey matter (GM) and white matter (WM) was extracted as the structural feature for each ROI.
60-1	10556-10559	For	_
60-2	10560-10564	sMRI	_
60-3	10565-10566	,	_
60-4	10567-10570	the	_
60-5	10571-10577	volume	_
60-6	10578-10580	of	_
60-7	10581-10585	grey	_
60-8	10586-10592	matter	_
60-9	10593-10594	(	_
60-10	10595-10597	GM	_
60-11	10598-10599	)	_
60-12	10600-10603	and	_
60-13	10604-10609	white	_
60-14	10610-10616	matter	_
60-15	10617-10618	(	_
60-16	10619-10621	WM	_
60-17	10622-10623	)	_
60-18	10624-10627	was	_
60-19	10628-10637	extracted	_
60-20	10638-10640	as	_
60-21	10641-10644	the	_
60-22	10645-10655	structural	_
60-23	10656-10663	feature	_
60-24	10664-10667	for	_
60-25	10668-10672	each	_
60-26	10673-10676	ROI	_
60-27	10677-10678	.	_

Text=For DTI, the fractional anisotropy (FA), radial diffusivity (RD) and mean diffusivity (MD) were extracted as the DTI features for each ROI.
61-1	10679-10682	For	_
61-2	10683-10686	DTI	_
61-3	10687-10688	,	_
61-4	10689-10692	the	_
61-5	10693-10703	fractional	_
61-6	10704-10714	anisotropy	_
61-7	10715-10716	(	_
61-8	10717-10719	FA	_
61-9	10720-10721	)	_
61-10	10722-10723	,	_
61-11	10724-10730	radial	_
61-12	10731-10742	diffusivity	_
61-13	10743-10744	(	_
61-14	10745-10747	RD	_
61-15	10748-10749	)	_
61-16	10750-10753	and	_
61-17	10754-10758	mean	_
61-18	10759-10770	diffusivity	_
61-19	10771-10772	(	_
61-20	10773-10775	MD	_
61-21	10776-10777	)	_
61-22	10778-10782	were	_
61-23	10783-10792	extracted	_
61-24	10793-10795	as	_
61-25	10796-10799	the	_
61-26	10800-10803	DTI	_
61-27	10804-10812	features	_
61-28	10813-10816	for	_
61-29	10817-10821	each	_
61-30	10822-10825	ROI	_
61-31	10826-10827	.	_

Text=By combining with the functional, structural and DTI features, a vector consisting of 94 variables (89 fMRI features, 2 sMRI features, and 3 DTI features) was constructed as multi-index vector for each ROI.
62-1	10828-10830	By	_
62-2	10831-10840	combining	_
62-3	10841-10845	with	_
62-4	10846-10849	the	_
62-5	10850-10860	functional	_
62-6	10861-10862	,	_
62-7	10863-10873	structural	_
62-8	10874-10877	and	_
62-9	10878-10881	DTI	_
62-10	10882-10890	features	_
62-11	10891-10892	,	_
62-12	10893-10894	a	_
62-13	10895-10901	vector	_
62-14	10902-10912	consisting	_
62-15	10913-10915	of	_
62-16	10916-10918	94	_
62-17	10919-10928	variables	_
62-18	10929-10930	(	_
62-19	10931-10933	89	_
62-20	10934-10938	fMRI	_
62-21	10939-10947	features	_
62-22	10948-10949	,	_
62-23	10950-10951	2	_
62-24	10952-10956	sMRI	_
62-25	10957-10965	features	_
62-26	10966-10967	,	_
62-27	10968-10971	and	_
62-28	10972-10973	3	_
62-29	10974-10977	DTI	_
62-30	10978-10986	features	_
62-31	10987-10988	)	_
62-32	10989-10992	was	_
62-33	10993-11004	constructed	_
62-34	11005-11007	as	_
62-35	11008-11019	multi-index	_
62-36	11020-11026	vector	_
62-37	11027-11030	for	_
62-38	11031-11035	each	_
62-39	11036-11039	ROI	_
62-40	11040-11041	.	_

Text=To avoid being overly biased by data scaling, the combined data was normalized by subtracting the mean and dividing by the standard deviation.
63-1	11042-11044	To	_
63-2	11045-11050	avoid	_
63-3	11051-11056	being	_
63-4	11057-11063	overly	_
63-5	11064-11070	biased	_
63-6	11071-11073	by	_
63-7	11074-11078	data	_
63-8	11079-11086	scaling	_
63-9	11087-11088	,	_
63-10	11089-11092	the	_
63-11	11093-11101	combined	_
63-12	11102-11106	data	_
63-13	11107-11110	was	_
63-14	11111-11121	normalized	_
63-15	11122-11124	by	_
63-16	11125-11136	subtracting	_
63-17	11137-11140	the	_
63-18	11141-11145	mean	_
63-19	11146-11149	and	_
63-20	11150-11158	dividing	_
63-21	11159-11161	by	_
63-22	11162-11165	the	_
63-23	11166-11174	standard	_
63-24	11175-11184	deviation	_
63-25	11185-11186	.	_

Text=The flowchart of the fusion data is shown in Fig 1.
64-1	11187-11190	The	_
64-2	11191-11200	flowchart	_
64-3	11201-11203	of	_
64-4	11204-11207	the	_
64-5	11208-11214	fusion	_
64-6	11215-11219	data	_
64-7	11220-11222	is	_
64-8	11223-11228	shown	_
64-9	11229-11231	in	_
64-10	11232-11235	Fig	_
64-11	11236-11237	1	_
64-12	11238-11239	.	_

Text=Multivariate analysis of variance Multivariate analysis of variance (MANOVA) is one of the multivariate approaches.
65-1	11240-11252	Multivariate	_
65-2	11253-11261	analysis	_
65-3	11262-11264	of	_
65-4	11265-11273	variance	_
65-5	11274-11286	Multivariate	_
65-6	11287-11295	analysis	_
65-7	11296-11298	of	_
65-8	11299-11307	variance	_
65-9	11308-11309	(	_
65-10	11310-11316	MANOVA	_
65-11	11317-11318	)	_
65-12	11319-11321	is	_
65-13	11322-11325	one	_
65-14	11326-11328	of	_
65-15	11329-11332	the	_
65-16	11333-11345	multivariate	_
65-17	11346-11356	approaches	_
65-18	11357-11358	.	_

Text=It is a statistical test procedure for comparing multivariate (population) means of several groups.
66-1	11359-11361	It	_
66-2	11362-11364	is	_
66-3	11365-11366	a	_
66-4	11367-11378	statistical	_
66-5	11379-11383	test	_
66-6	11384-11393	procedure	_
66-7	11394-11397	for	_
66-8	11398-11407	comparing	_
66-9	11408-11420	multivariate	_
66-10	11421-11422	(	_
66-11	11423-11433	population	_
66-12	11434-11435	)	_
66-13	11436-11441	means	_
66-14	11442-11444	of	_
66-15	11445-11452	several	_
66-16	11453-11459	groups	_
66-17	11460-11461	.	_

Text=The multivariate approach has been adapted for single-mode fMRI data, sMRI data and DTI data in earlier studies.
67-1	11462-11465	The	_
67-2	11466-11478	multivariate	_
67-3	11479-11487	approach	_
67-4	11488-11491	has	_
67-5	11492-11496	been	_
67-6	11497-11504	adapted	_
67-7	11505-11508	for	_
67-8	11509-11520	single-mode	_
67-9	11521-11525	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
67-10	11526-11530	data	_
67-11	11531-11532	,	_
67-12	11533-11537	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
67-13	11538-11542	data	_
67-14	11543-11546	and	_
67-15	11547-11550	DTI	_
67-16	11551-11555	data	_
67-17	11556-11558	in	_
67-18	11559-11566	earlier	_
67-19	11567-11574	studies	_
67-20	11575-11576	.	_

Text=Suppose there are G different groups (patient, healthy control, etc) with ng individuals in the g-th group.
68-1	11577-11584	Suppose	_
68-2	11585-11590	there	_
68-3	11591-11594	are	_
68-4	11595-11596	G	_
68-5	11597-11606	different	_
68-6	11607-11613	groups	_
68-7	11614-11615	(	_
68-8	11616-11623	patient	_
68-9	11624-11625	,	_
68-10	11626-11633	healthy	_
68-11	11634-11641	control	_
68-12	11642-11643	,	_
68-13	11644-11647	etc	_
68-14	11648-11649	)	_
68-15	11650-11654	with	_
68-16	11655-11657	ng	_
68-17	11658-11669	individuals	_
68-18	11670-11672	in	_
68-19	11673-11676	the	_
68-20	11677-11681	g-th	_
68-21	11682-11687	group	_
68-22	11688-11689	.	_

Text=For each individual k in the g-th group, there are m measures to form a measurement vector where is the i-th measurement of the k-th sample on the g-th group.
69-1	11690-11693	For	_
69-2	11694-11698	each	_
69-3	11699-11709	individual	_
69-4	11710-11711	k	_
69-5	11712-11714	in	_
69-6	11715-11718	the	_
69-7	11719-11723	g-th	_
69-8	11724-11729	group	_
69-9	11730-11731	,	_
69-10	11732-11737	there	_
69-11	11738-11741	are	_
69-12	11742-11743	m	_
69-13	11744-11752	measures	_
69-14	11753-11755	to	_
69-15	11756-11760	form	_
69-16	11761-11762	a	_
69-17	11763-11774	measurement	_
69-18	11775-11781	vector	_
69-19	11782-11787	where	_
69-20	11788-11790	is	_
69-21	11791-11794	the	_
69-22	11795-11799	i-th	_
69-23	11800-11811	measurement	_
69-24	11812-11814	of	_
69-25	11815-11818	the	_
69-26	11819-11823	k-th	_
69-27	11824-11830	sample	_
69-28	11831-11833	on	_
69-29	11834-11837	the	_
69-30	11838-11842	g-th	_
69-31	11843-11848	group	_
69-32	11849-11850	.	_

Text=We assume that Xgk follows a multivariate normal distribution Xg ∼ Nm (μg, ∑), g = 1,2, …, G In order to test the ability of each ROI to distinguish the different groups, we define the following measures: the within-group dispersion matrix W = [wij] m×m, the between-group dispersion matrix B = [bij] m×m and the total dispersion matrix T = [Tij] m×m, where The ordinary Wilk's Lambda statistic was defined as follows: The smaller the value of λ is, the bigger the difference of different groups are.
70-1	11851-11853	We	_
70-2	11854-11860	assume	_
70-3	11861-11865	that	_
70-4	11866-11869	Xgk	_
70-5	11870-11877	follows	_
70-6	11878-11879	a	_
70-7	11880-11892	multivariate	_
70-8	11893-11899	normal	_
70-9	11900-11912	distribution	_
70-10	11913-11915	Xg	_
70-11	11916-11917	∼	_
70-12	11918-11920	Nm	_
70-13	11921-11922	(	_
70-14	11923-11925	μg	_
70-15	11926-11927	,	_
70-16	11928-11929	∑	_
70-17	11930-11931	)	_
70-18	11932-11933	,	_
70-19	11934-11935	g	_
70-20	11936-11937	=	_
70-21	11938-11941	1,2	_
70-22	11942-11943	,	_
70-23	11944-11945	…	_
70-24	11946-11947	,	_
70-25	11948-11949	G	_
70-26	11950-11952	In	_
70-27	11953-11958	order	_
70-28	11959-11961	to	_
70-29	11962-11966	test	_
70-30	11967-11970	the	_
70-31	11971-11978	ability	_
70-32	11979-11981	of	_
70-33	11982-11986	each	_
70-34	11987-11990	ROI	_
70-35	11991-11993	to	_
70-36	11994-12005	distinguish	_
70-37	12006-12009	the	_
70-38	12010-12019	different	_
70-39	12020-12026	groups	_
70-40	12027-12028	,	_
70-41	12029-12031	we	_
70-42	12032-12038	define	_
70-43	12039-12042	the	_
70-44	12043-12052	following	_
70-45	12053-12061	measures	_
70-46	12062-12063	:	_
70-47	12064-12067	the	_
70-48	12068-12080	within-group	_
70-49	12081-12091	dispersion	_
70-50	12092-12098	matrix	_
70-51	12099-12100	W	_
70-52	12101-12102	=	_
70-53	12103-12104	[	_
70-54	12105-12108	wij	_
70-55	12109-12110	]	_
70-56	12111-12114	m×m	_
70-57	12115-12116	,	_
70-58	12117-12120	the	_
70-59	12121-12134	between-group	_
70-60	12135-12145	dispersion	_
70-61	12146-12152	matrix	_
70-62	12153-12154	B	_
70-63	12155-12156	=	_
70-64	12157-12158	[	_
70-65	12159-12162	bij	_
70-66	12163-12164	]	_
70-67	12165-12168	m×m	_
70-68	12169-12172	and	_
70-69	12173-12176	the	_
70-70	12177-12182	total	_
70-71	12183-12193	dispersion	_
70-72	12194-12200	matrix	_
70-73	12201-12202	T	_
70-74	12203-12204	=	_
70-75	12205-12206	[	_
70-76	12207-12210	Tij	_
70-77	12211-12212	]	_
70-78	12213-12216	m×m	_
70-79	12217-12218	,	_
70-80	12219-12224	where	_
70-81	12225-12228	The	_
70-82	12229-12237	ordinary	_
70-83	12238-12242	Wilk	_
70-84	12243-12245	's	_
70-85	12246-12252	Lambda	_
70-86	12253-12262	statistic	_
70-87	12263-12266	was	_
70-88	12267-12274	defined	_
70-89	12275-12277	as	_
70-90	12278-12285	follows	_
70-91	12286-12287	:	_
70-92	12288-12291	The	_
70-93	12292-12299	smaller	_
70-94	12300-12303	the	_
70-95	12304-12309	value	_
70-96	12310-12312	of	_
70-97	12313-12314	λ	_
70-98	12315-12317	is	_
70-99	12318-12319	,	_
70-100	12320-12323	the	_
70-101	12324-12330	bigger	_
70-102	12331-12334	the	_
70-103	12335-12345	difference	_
70-104	12346-12348	of	_
70-105	12349-12358	different	_
70-106	12359-12365	groups	_
70-107	12366-12369	are	_
70-108	12370-12371	.	_

Text=In order to calculate the p value of each Wilk ’ s Lambda statistics, we transform it to a chi-square distribution with the following formulation: Bartlett showed that if H0: μ1 = μ2 = … = μG is true and n is large, λ has approximately a chi-square distribution with m× (G−1) degrees of freedom Support vector machine (SVM) classifier The SVM is a machine learning approach for a two-class classification problem.
71-1	12372-12374	In	_
71-2	12375-12380	order	_
71-3	12381-12383	to	_
71-4	12384-12393	calculate	_
71-5	12394-12397	the	_
71-6	12398-12399	p	_
71-7	12400-12405	value	_
71-8	12406-12408	of	_
71-9	12409-12413	each	_
71-10	12414-12418	Wilk	_
71-11	12419-12420	’	_
71-12	12421-12422	s	_
71-13	12423-12429	Lambda	_
71-14	12430-12440	statistics	_
71-15	12441-12442	,	_
71-16	12443-12445	we	_
71-17	12446-12455	transform	_
71-18	12456-12458	it	_
71-19	12459-12461	to	_
71-20	12462-12463	a	_
71-21	12464-12474	chi-square	_
71-22	12475-12487	distribution	_
71-23	12488-12492	with	_
71-24	12493-12496	the	_
71-25	12497-12506	following	_
71-26	12507-12518	formulation	_
71-27	12519-12520	:	_
71-28	12521-12529	Bartlett	_
71-29	12530-12536	showed	_
71-30	12537-12541	that	_
71-31	12542-12544	if	_
71-32	12545-12547	H0	_
71-33	12548-12549	:	_
71-34	12550-12552	μ1	_
71-35	12553-12554	=	_
71-36	12555-12557	μ2	_
71-37	12558-12559	=	_
71-38	12560-12561	…	_
71-39	12562-12563	=	_
71-40	12564-12566	μG	_
71-41	12567-12569	is	_
71-42	12570-12574	true	_
71-43	12575-12578	and	_
71-44	12579-12580	n	_
71-45	12581-12583	is	_
71-46	12584-12589	large	_
71-47	12590-12591	,	_
71-48	12592-12593	λ	_
71-49	12594-12597	has	_
71-50	12598-12611	approximately	_
71-51	12612-12613	a	_
71-52	12614-12624	chi-square	_
71-53	12625-12637	distribution	_
71-54	12638-12642	with	_
71-55	12643-12645	m×	_
71-56	12646-12647	(	_
71-57	12648-12651	G−1	_
71-58	12652-12653	)	_
71-59	12654-12661	degrees	_
71-60	12662-12664	of	_
71-61	12665-12672	freedom	_
71-62	12673-12680	Support	_
71-63	12681-12687	vector	_
71-64	12688-12695	machine	_
71-65	12696-12697	(	_
71-66	12698-12701	SVM	_
71-67	12702-12703	)	_
71-68	12704-12714	classifier	_
71-69	12715-12718	The	_
71-70	12719-12722	SVM	_
71-71	12723-12725	is	_
71-72	12726-12727	a	_
71-73	12728-12735	machine	_
71-74	12736-12744	learning	_
71-75	12745-12753	approach	_
71-76	12754-12757	for	_
71-77	12758-12759	a	_
71-78	12760-12769	two-class	_
71-79	12770-12784	classification	_
71-80	12785-12792	problem	_
71-81	12793-12794	.	_

Text=Since first proposed by Vapnik as a logistical extension of statistical learning theory, SVM has become widely used in many areas because of their ability to handle very high-dimensional data, and their accuracy in classification and prediction.
72-1	12795-12800	Since	_
72-2	12801-12806	first	_
72-3	12807-12815	proposed	_
72-4	12816-12818	by	_
72-5	12819-12825	Vapnik	_
72-6	12826-12828	as	_
72-7	12829-12830	a	_
72-8	12831-12841	logistical	_
72-9	12842-12851	extension	_
72-10	12852-12854	of	_
72-11	12855-12866	statistical	_
72-12	12867-12875	learning	_
72-13	12876-12882	theory	_
72-14	12883-12884	,	_
72-15	12885-12888	SVM	_
72-16	12889-12892	has	_
72-17	12893-12899	become	_
72-18	12900-12906	widely	_
72-19	12907-12911	used	_
72-20	12912-12914	in	_
72-21	12915-12919	many	_
72-22	12920-12925	areas	_
72-23	12926-12933	because	_
72-24	12934-12936	of	_
72-25	12937-12942	their	_
72-26	12943-12950	ability	_
72-27	12951-12953	to	_
72-28	12954-12960	handle	_
72-29	12961-12965	very	_
72-30	12966-12982	high-dimensional	_
72-31	12983-12987	data	_
72-32	12988-12989	,	_
72-33	12990-12993	and	_
72-34	12994-12999	their	_
72-35	13000-13008	accuracy	_
72-36	13009-13011	in	_
72-37	13012-13026	classification	_
72-38	13027-13030	and	_
72-39	13031-13041	prediction	_
72-40	13042-13043	.	_

Text=SVM has become increasingly used in studies of psychiatric and neurological disorders, the rationale for which is that it is able to account for the inter-relationship between different within-modality measures for each subject by considering them simultaneously.
73-1	13044-13047	SVM	_
73-2	13048-13051	has	_
73-3	13052-13058	become	_
73-4	13059-13071	increasingly	_
73-5	13072-13076	used	_
73-6	13077-13079	in	_
73-7	13080-13087	studies	_
73-8	13088-13090	of	_
73-9	13091-13102	psychiatric	_
73-10	13103-13106	and	_
73-11	13107-13119	neurological	_
73-12	13120-13129	disorders	_
73-13	13130-13131	,	_
73-14	13132-13135	the	_
73-15	13136-13145	rationale	_
73-16	13146-13149	for	_
73-17	13150-13155	which	_
73-18	13156-13158	is	_
73-19	13159-13163	that	_
73-20	13164-13166	it	_
73-21	13167-13169	is	_
73-22	13170-13174	able	_
73-23	13175-13177	to	_
73-24	13178-13185	account	_
73-25	13186-13189	for	_
73-26	13190-13193	the	_
73-27	13194-13212	inter-relationship	_
73-28	13213-13220	between	_
73-29	13221-13230	different	_
73-30	13231-13246	within-modality	_
73-31	13247-13255	measures	_
73-32	13256-13259	for	_
73-33	13260-13264	each	_
73-34	13265-13272	subject	_
73-35	13273-13275	by	_
73-36	13276-13287	considering	_
73-37	13288-13292	them	_
73-38	13293-13307	simultaneously	_
73-39	13308-13309	.	_

Text=SVM conceptually implements the idea that vectors are non-linearly mapped to a very high dimensional feature space.
74-1	13310-13313	SVM	_
74-2	13314-13326	conceptually	_
74-3	13327-13337	implements	_
74-4	13338-13341	the	_
74-5	13342-13346	idea	_
74-6	13347-13351	that	_
74-7	13352-13359	vectors	_
74-8	13360-13363	are	_
74-9	13364-13376	non-linearly	_
74-10	13377-13383	mapped	_
74-11	13384-13386	to	_
74-12	13387-13388	a	_
74-13	13389-13393	very	_
74-14	13394-13398	high	_
74-15	13399-13410	dimensional	_
74-16	13411-13418	feature	_
74-17	13419-13424	space	_
74-18	13425-13426	.	_

Text=In the feature space, a linear separation surface is created to separate the training data by maximizing the margin between the vectors of the two classes.
75-1	13427-13429	In	_
75-2	13430-13433	the	_
75-3	13434-13441	feature	_
75-4	13442-13447	space	_
75-5	13448-13449	,	_
75-6	13450-13451	a	_
75-7	13452-13458	linear	_
75-8	13459-13469	separation	_
75-9	13470-13477	surface	_
75-10	13478-13480	is	_
75-11	13481-13488	created	_
75-12	13489-13491	to	_
75-13	13492-13500	separate	_
75-14	13501-13504	the	_
75-15	13505-13513	training	_
75-16	13514-13518	data	_
75-17	13519-13521	by	_
75-18	13522-13532	maximizing	_
75-19	13533-13536	the	_
75-20	13537-13543	margin	_
75-21	13544-13551	between	_
75-22	13552-13555	the	_
75-23	13556-13563	vectors	_
75-24	13564-13566	of	_
75-25	13567-13570	the	_
75-26	13571-13574	two	_
75-27	13575-13582	classes	_
75-28	13583-13584	.	_

Text=The training ends with the definition of a decision surface that divides the space into two sub-spaces.
76-1	13585-13588	The	_
76-2	13589-13597	training	_
76-3	13598-13602	ends	_
76-4	13603-13607	with	_
76-5	13608-13611	the	_
76-6	13612-13622	definition	_
76-7	13623-13625	of	_
76-8	13626-13627	a	_
76-9	13628-13636	decision	_
76-10	13637-13644	surface	_
76-11	13645-13649	that	_
76-12	13650-13657	divides	_
76-13	13658-13661	the	_
76-14	13662-13667	space	_
76-15	13668-13672	into	_
76-16	13673-13676	two	_
76-17	13677-13687	sub-spaces	_
76-18	13688-13689	.	_

Text=Each sub-space corresponds to one class of the training data.
77-1	13690-13694	Each	_
77-2	13695-13704	sub-space	_
77-3	13705-13716	corresponds	_
77-4	13717-13719	to	_
77-5	13720-13723	one	_
77-6	13724-13729	class	_
77-7	13730-13732	of	_
77-8	13733-13736	the	_
77-9	13737-13745	training	_
77-10	13746-13750	data	_
77-11	13751-13752	.	_

Text=Once the training is completed, the test data are mapped to the feature space.
78-1	13753-13757	Once	_
78-2	13758-13761	the	_
78-3	13762-13770	training	_
78-4	13771-13773	is	_
78-5	13774-13783	completed	_
78-6	13784-13785	,	_
78-7	13786-13789	the	_
78-8	13790-13794	test	_
78-9	13795-13799	data	_
78-10	13800-13803	are	_
78-11	13804-13810	mapped	_
78-12	13811-13813	to	_
78-13	13814-13817	the	_
78-14	13818-13825	feature	_
78-15	13826-13831	space	_
78-16	13832-13833	.	_

Text=A class is then assigned to the test data depending on which sub-space they are mapped to.
79-1	13834-13835	A	_
79-2	13836-13841	class	_
79-3	13842-13844	is	_
79-4	13845-13849	then	_
79-5	13850-13858	assigned	_
79-6	13859-13861	to	_
79-7	13862-13865	the	_
79-8	13866-13870	test	_
79-9	13871-13875	data	_
79-10	13876-13885	depending	_
79-11	13886-13888	on	_
79-12	13889-13894	which	_
79-13	13895-13904	sub-space	_
79-14	13905-13909	they	_
79-15	13910-13913	are	_
79-16	13914-13920	mapped	_
79-17	13921-13923	to	_
79-18	13924-13925	.	_

Text=In this paper, a SVM toolkit named libsvm written by Chih-Jen Lin from Taiwan university (http: //www.csie.ntu.edu.tw/~cjlin/libsvm/) is used.
80-1	13926-13928	In	_
80-2	13929-13933	this	_
80-3	13934-13939	paper	_
80-4	13940-13941	,	_
80-5	13942-13943	a	_
80-6	13944-13947	SVM	_
80-7	13948-13955	toolkit	_
80-8	13956-13961	named	_
80-9	13962-13968	libsvm	_
80-10	13969-13976	written	_
80-11	13977-13979	by	_
80-12	13980-13988	Chih-Jen	_
80-13	13989-13992	Lin	_
80-14	13993-13997	from	_
80-15	13998-14004	Taiwan	_
80-16	14005-14015	university	_
80-17	14016-14017	(	_
80-18	14018-14022	http	_
80-19	14023-14024	:	_
80-20	14025-14061	//www.csie.ntu.edu.tw/~cjlin/libsvm/	_
80-21	14062-14063	)	_
80-22	14064-14066	is	_
80-23	14067-14071	used	_
80-24	14072-14073	.	_

Text=Specifically, the whole brain single-modal or multi-modal features are applied to the raw input matrix.
81-1	14074-14086	Specifically	_
81-2	14087-14088	,	_
81-3	14089-14092	the	_
81-4	14093-14098	whole	_
81-5	14099-14104	brain	_
81-6	14105-14117	single-modal	_
81-7	14118-14120	or	_
81-8	14121-14132	multi-modal	_
81-9	14133-14141	features	_
81-10	14142-14145	are	_
81-11	14146-14153	applied	_
81-12	14154-14156	to	_
81-13	14157-14160	the	_
81-14	14161-14164	raw	_
81-15	14165-14170	input	_
81-16	14171-14177	matrix	_
81-17	14178-14179	.	_

Text=Statistically significant features (p-value of two-sample t-test being smaller than a threshold) are selected.
82-1	14180-14193	Statistically	_
82-2	14194-14205	significant	_
82-3	14206-14214	features	_
82-4	14215-14216	(	_
82-5	14217-14224	p-value	_
82-6	14225-14227	of	_
82-7	14228-14238	two-sample	_
82-8	14239-14245	t-test	_
82-9	14246-14251	being	_
82-10	14252-14259	smaller	_
82-11	14260-14264	than	_
82-12	14265-14266	a	_
82-13	14267-14276	threshold	_
82-14	14277-14278	)	_
82-15	14279-14282	are	_
82-16	14283-14291	selected	_
82-17	14292-14293	.	_

Text=Different kernel types (linear, t = 0; polynomial, t = 1; radial basis function, t = 2) and different trade-off parameter C (0.001, 0.01, 0.1, 1, 10, 100, 1000, 10000) is tried to obtain the highest accuracy rate.
83-1	14294-14303	Different	_
83-2	14304-14310	kernel	_
83-3	14311-14316	types	_
83-4	14317-14318	(	_
83-5	14319-14325	linear	_
83-6	14326-14327	,	_
83-7	14328-14329	t	_
83-8	14330-14331	=	_
83-9	14332-14333	0	_
83-10	14334-14335	;	_
83-11	14336-14346	polynomial	_
83-12	14347-14348	,	_
83-13	14349-14350	t	_
83-14	14351-14352	=	_
83-15	14353-14354	1	_
83-16	14355-14356	;	_
83-17	14357-14363	radial	_
83-18	14364-14369	basis	_
83-19	14370-14378	function	_
83-20	14379-14380	,	_
83-21	14381-14382	t	_
83-22	14383-14384	=	_
83-23	14385-14386	2	_
83-24	14387-14388	)	_
83-25	14389-14392	and	_
83-26	14393-14402	different	_
83-27	14403-14412	trade-off	_
83-28	14413-14422	parameter	_
83-29	14423-14424	C	_
83-30	14425-14426	(	_
83-31	14427-14432	0.001	_
83-32	14433-14434	,	_
83-33	14435-14439	0.01	_
83-34	14440-14441	,	_
83-35	14442-14445	0.1	_
83-36	14446-14447	,	_
83-37	14448-14449	1	_
83-38	14450-14451	,	_
83-39	14452-14454	10	_
83-40	14455-14456	,	_
83-41	14457-14460	100	_
83-42	14461-14462	,	_
83-43	14463-14467	1000	_
83-44	14468-14469	,	_
83-45	14470-14475	10000	_
83-46	14476-14477	)	_
83-47	14478-14480	is	_
83-48	14481-14486	tried	_
83-49	14487-14489	to	_
83-50	14490-14496	obtain	_
83-51	14497-14500	the	_
83-52	14501-14508	highest	_
83-53	14509-14517	accuracy	_
83-54	14518-14522	rate	_
83-55	14523-14524	.	_

Text=To measure the test performance and to validate the classifier, we implement 10-fold cross-validation with three levels of nesting for tuning and validating our model.
84-1	14525-14527	To	_
84-2	14528-14535	measure	_
84-3	14536-14539	the	_
84-4	14540-14544	test	_
84-5	14545-14556	performance	_
84-6	14557-14560	and	_
84-7	14561-14563	to	_
84-8	14564-14572	validate	_
84-9	14573-14576	the	_
84-10	14577-14587	classifier	_
84-11	14588-14589	,	_
84-12	14590-14592	we	_
84-13	14593-14602	implement	_
84-14	14603-14610	10-fold	_
84-15	14611-14627	cross-validation	_
84-16	14628-14632	with	_
84-17	14633-14638	three	_
84-18	14639-14645	levels	_
84-19	14646-14648	of	_
84-20	14649-14656	nesting	_
84-21	14657-14660	for	_
84-22	14661-14667	tuning	_
84-23	14668-14671	and	_
84-24	14672-14682	validating	_
84-25	14683-14686	our	_
84-26	14687-14692	model	_
84-27	14693-14694	.	_

Text=That is, for each iteration, eight folds of the subjects are used for training, one fold is used to optimize the parameters and another fold for testing.
85-1	14695-14699	That	_
85-2	14700-14702	is	_
85-3	14703-14704	,	_
85-4	14705-14708	for	_
85-5	14709-14713	each	_
85-6	14714-14723	iteration	_
85-7	14724-14725	,	_
85-8	14726-14731	eight	_
85-9	14732-14737	folds	_
85-10	14738-14740	of	_
85-11	14741-14744	the	_
85-12	14745-14753	subjects	_
85-13	14754-14757	are	_
85-14	14758-14762	used	_
85-15	14763-14766	for	_
85-16	14767-14775	training	_
85-17	14776-14777	,	_
85-18	14778-14781	one	_
85-19	14782-14786	fold	_
85-20	14787-14789	is	_
85-21	14790-14794	used	_
85-22	14795-14797	to	_
85-23	14798-14806	optimize	_
85-24	14807-14810	the	_
85-25	14811-14821	parameters	_
85-26	14822-14825	and	_
85-27	14826-14833	another	_
85-28	14834-14838	fold	_
85-29	14839-14842	for	_
85-30	14843-14850	testing	_
85-31	14851-14852	.	_

Text=The procedure is iterated for 100 times, and the meandiscrimination accuracy, sensitivity and specificity are reported with the best parameter setting.
86-1	14853-14856	The	_
86-2	14857-14866	procedure	_
86-3	14867-14869	is	_
86-4	14870-14878	iterated	_
86-5	14879-14882	for	_
86-6	14883-14886	100	_
86-7	14887-14892	times	_
86-8	14893-14894	,	_
86-9	14895-14898	and	_
86-10	14899-14902	the	_
86-11	14903-14921	meandiscrimination	_
86-12	14922-14930	accuracy	_
86-13	14931-14932	,	_
86-14	14933-14944	sensitivity	_
86-15	14945-14948	and	_
86-16	14949-14960	specificity	_
86-17	14961-14964	are	_
86-18	14965-14973	reported	_
86-19	14974-14978	with	_
86-20	14979-14982	the	_
86-21	14983-14987	best	_
86-22	14988-14997	parameter	_
86-23	14998-15005	setting	_
86-24	15006-15007	.	_

Text=The features are selected in each cross-validation run and the features with high weights during the 100 iterations are the optimized features for each classifier.
87-1	15008-15011	The	_
87-2	15012-15020	features	_
87-3	15021-15024	are	_
87-4	15025-15033	selected	_
87-5	15034-15036	in	_
87-6	15037-15041	each	_
87-7	15042-15058	cross-validation	_
87-8	15059-15062	run	_
87-9	15063-15066	and	_
87-10	15067-15070	the	_
87-11	15071-15079	features	_
87-12	15080-15084	with	_
87-13	15085-15089	high	_
87-14	15090-15097	weights	_
87-15	15098-15104	during	_
87-16	15105-15108	the	_
87-17	15109-15112	100	_
87-18	15113-15123	iterations	_
87-19	15124-15127	are	_
87-20	15128-15131	the	_
87-21	15132-15141	optimized	_
87-22	15142-15150	features	_
87-23	15151-15154	for	_
87-24	15155-15159	each	_
87-25	15160-15170	classifier	_
87-26	15171-15172	.	_

Text=Choosing the generalization rate as the statistic, permutation tests are employed to estimate the statistical significance of the observed classification accuracy.
88-1	15173-15181	Choosing	_
88-2	15182-15185	the	_
88-3	15186-15200	generalization	_
88-4	15201-15205	rate	_
88-5	15206-15208	as	_
88-6	15209-15212	the	_
88-7	15213-15222	statistic	_
88-8	15223-15224	,	_
88-9	15225-15236	permutation	_
88-10	15237-15242	tests	_
88-11	15243-15246	are	_
88-12	15247-15255	employed	_
88-13	15256-15258	to	_
88-14	15259-15267	estimate	_
88-15	15268-15271	the	_
88-16	15272-15283	statistical	_
88-17	15284-15296	significance	_
88-18	15297-15299	of	_
88-19	15300-15303	the	_
88-20	15304-15312	observed	_
88-21	15313-15327	classification	_
88-22	15328-15336	accuracy	_
88-23	15337-15338	.	_

Text=In permutation testing, the class labels of the training data are randomly permuted prior to training.
89-1	15339-15341	In	_
89-2	15342-15353	permutation	_
89-3	15354-15361	testing	_
89-4	15362-15363	,	_
89-5	15364-15367	the	_
89-6	15368-15373	class	_
89-7	15374-15380	labels	_
89-8	15381-15383	of	_
89-9	15384-15387	the	_
89-10	15388-15396	training	_
89-11	15397-15401	data	_
89-12	15402-15405	are	_
89-13	15406-15414	randomly	_
89-14	15415-15423	permuted	_
89-15	15424-15429	prior	_
89-16	15430-15432	to	_
89-17	15433-15441	training	_
89-18	15442-15443	.	_

Text=Cross-validation is then performed on the permuted training set, and the permutation is repeated 100 times.
90-1	15444-15460	Cross-validation	_
90-2	15461-15463	is	_
90-3	15464-15468	then	_
90-4	15469-15478	performed	_
90-5	15479-15481	on	_
90-6	15482-15485	the	_
90-7	15486-15494	permuted	_
90-8	15495-15503	training	_
90-9	15504-15507	set	_
90-10	15508-15509	,	_
90-11	15510-15513	and	_
90-12	15514-15517	the	_
90-13	15518-15529	permutation	_
90-14	15530-15532	is	_
90-15	15533-15541	repeated	_
90-16	15542-15545	100	_
90-17	15546-15551	times	_
90-18	15552-15553	.	_

Text=The p-value represents the probability of observing a classification prediction rate in a permutation testing no less than the discrimination accuracy.
91-1	15554-15557	The	_
91-2	15558-15565	p-value	_
91-3	15566-15576	represents	_
91-4	15577-15580	the	_
91-5	15581-15592	probability	_
91-6	15593-15595	of	_
91-7	15596-15605	observing	_
91-8	15606-15607	a	_
91-9	15608-15622	classification	_
91-10	15623-15633	prediction	_
91-11	15634-15638	rate	_
91-12	15639-15641	in	_
91-13	15642-15643	a	_
91-14	15644-15655	permutation	_
91-15	15656-15663	testing	_
91-16	15664-15666	no	_
91-17	15667-15671	less	_
91-18	15672-15676	than	_
91-19	15677-15680	the	_
91-20	15681-15695	discrimination	_
91-21	15696-15704	accuracy	_
91-22	15705-15706	.	_

Text=If the p-value is smaller than the significant level, we reject the null hypothesis that the classifier could not learn the relationship between the data and the labels reliably and declare that the classifier learns the relationship with a probability of being wrong of at most p.The flowchart of the pattern recognition is shown in S1 Fig.
92-1	15707-15709	If	_
92-2	15710-15713	the	_
92-3	15714-15721	p-value	_
92-4	15722-15724	is	_
92-5	15725-15732	smaller	_
92-6	15733-15737	than	_
92-7	15738-15741	the	_
92-8	15742-15753	significant	_
92-9	15754-15759	level	_
92-10	15760-15761	,	_
92-11	15762-15764	we	_
92-12	15765-15771	reject	_
92-13	15772-15775	the	_
92-14	15776-15780	null	_
92-15	15781-15791	hypothesis	_
92-16	15792-15796	that	_
92-17	15797-15800	the	_
92-18	15801-15811	classifier	_
92-19	15812-15817	could	_
92-20	15818-15821	not	_
92-21	15822-15827	learn	_
92-22	15828-15831	the	_
92-23	15832-15844	relationship	_
92-24	15845-15852	between	_
92-25	15853-15856	the	_
92-26	15857-15861	data	_
92-27	15862-15865	and	_
92-28	15866-15869	the	_
92-29	15870-15876	labels	_
92-30	15877-15885	reliably	_
92-31	15886-15889	and	_
92-32	15890-15897	declare	_
92-33	15898-15902	that	_
92-34	15903-15906	the	_
92-35	15907-15917	classifier	_
92-36	15918-15924	learns	_
92-37	15925-15928	the	_
92-38	15929-15941	relationship	_
92-39	15942-15946	with	_
92-40	15947-15948	a	_
92-41	15949-15960	probability	_
92-42	15961-15963	of	_
92-43	15964-15969	being	_
92-44	15970-15975	wrong	_
92-45	15976-15978	of	_
92-46	15979-15981	at	_
92-47	15982-15986	most	_
92-48	15987-15992	p.The	_
92-49	15993-16002	flowchart	_
92-50	16003-16005	of	_
92-51	16006-16009	the	_
92-52	16010-16017	pattern	_
92-53	16018-16029	recognition	_
92-54	16030-16032	is	_
92-55	16033-16038	shown	_
92-56	16039-16041	in	_
92-57	16042-16044	S1	_
92-58	16045-16048	Fig	_
92-59	16049-16050	.	_

Text=Diversity of individual modalities in classification As mentioned earlier, a lot of studies have indicated that different modalities contain complementary information for discrimination.
93-1	16051-16060	Diversity	_
93-2	16061-16063	of	_
93-3	16064-16074	individual	_
93-4	16075-16085	modalities	_
93-5	16086-16088	in	_
93-6	16089-16103	classification	_
93-7	16104-16106	As	_
93-8	16107-16116	mentioned	_
93-9	16117-16124	earlier	_
93-10	16125-16126	,	_
93-11	16127-16128	a	_
93-12	16129-16132	lot	_
93-13	16133-16135	of	_
93-14	16136-16143	studies	_
93-15	16144-16148	have	_
93-16	16149-16158	indicated	_
93-17	16159-16163	that	_
93-18	16164-16173	different	_
93-19	16174-16184	modalities	_
93-20	16185-16192	contain	_
93-21	16193-16206	complementary	_
93-22	16207-16218	information	_
93-23	16219-16222	for	_
93-24	16223-16237	discrimination	_
93-25	16238-16239	.	_

Text=In order to quantitatively measure the discrimination similarity and diversity between any two different modalities, we use Jaccard similarity coefficient and Kappa index to achieve these goals.
94-1	16240-16242	In	_
94-2	16243-16248	order	_
94-3	16249-16251	to	_
94-4	16252-16266	quantitatively	_
94-5	16267-16274	measure	_
94-6	16275-16278	the	_
94-7	16279-16293	discrimination	_
94-8	16294-16304	similarity	_
94-9	16305-16308	and	_
94-10	16309-16318	diversity	_
94-11	16319-16326	between	_
94-12	16327-16330	any	_
94-13	16331-16334	two	_
94-14	16335-16344	different	_
94-15	16345-16355	modalities	_
94-16	16356-16357	,	_
94-17	16358-16360	we	_
94-18	16361-16364	use	_
94-19	16365-16372	Jaccard	_
94-20	16373-16383	similarity	_
94-21	16384-16395	coefficient	_
94-22	16396-16399	and	_
94-23	16400-16405	Kappa	_
94-24	16406-16411	index	_
94-25	16412-16414	to	_
94-26	16415-16422	achieve	_
94-27	16423-16428	these	_
94-28	16429-16434	goals	_
94-29	16435-16436	.	_

Text=The Jaccard coefficient measures similarity between finite sample sets, and is defined as the size of the intersection divided by the size of the union of the sample sets.
95-1	16437-16440	The	_
95-2	16441-16448	Jaccard	_
95-3	16449-16460	coefficient	_
95-4	16461-16469	measures	_
95-5	16470-16480	similarity	_
95-6	16481-16488	between	_
95-7	16489-16495	finite	_
95-8	16496-16502	sample	_
95-9	16503-16507	sets	_
95-10	16508-16509	,	_
95-11	16510-16513	and	_
95-12	16514-16516	is	_
95-13	16517-16524	defined	_
95-14	16525-16527	as	_
95-15	16528-16531	the	_
95-16	16532-16536	size	_
95-17	16537-16539	of	_
95-18	16540-16543	the	_
95-19	16544-16556	intersection	_
95-20	16557-16564	divided	_
95-21	16565-16567	by	_
95-22	16568-16571	the	_
95-23	16572-16576	size	_
95-24	16577-16579	of	_
95-25	16580-16583	the	_
95-26	16584-16589	union	_
95-27	16590-16592	of	_
95-28	16593-16596	the	_
95-29	16597-16603	sample	_
95-30	16604-16608	sets	_
95-31	16609-16610	.	_

Text=Cohen's kappa measures the agreement between two raters who each classify N items into C mutually exclusive categories.
96-1	16611-16616	Cohen	_
96-2	16617-16619	's	_
96-3	16620-16625	kappa	_
96-4	16626-16634	measures	_
96-5	16635-16638	the	_
96-6	16639-16648	agreement	_
96-7	16649-16656	between	_
96-8	16657-16660	two	_
96-9	16661-16667	raters	_
96-10	16668-16671	who	_
96-11	16672-16676	each	_
96-12	16677-16685	classify	_
96-13	16686-16687	N	_
96-14	16688-16693	items	_
96-15	16694-16698	into	_
96-16	16699-16700	C	_
96-17	16701-16709	mutually	_
96-18	16710-16719	exclusive	_
96-19	16720-16730	categories	_
96-20	16731-16732	.	_

Text=The equation for kappa is: Where Pr (a) is the relative observed agreement among raters, and Pr (e) is the hypothetical probability of chance agreement, using the observed data to calculate the probabilities of each observer randomly staying each category.
97-1	16733-16736	The	_
97-2	16737-16745	equation	_
97-3	16746-16749	for	_
97-4	16750-16755	kappa	_
97-5	16756-16758	is	_
97-6	16759-16760	:	_
97-7	16761-16766	Where	_
97-8	16767-16769	Pr	_
97-9	16770-16771	(	_
97-10	16772-16773	a	_
97-11	16774-16775	)	_
97-12	16776-16778	is	_
97-13	16779-16782	the	_
97-14	16783-16791	relative	_
97-15	16792-16800	observed	_
97-16	16801-16810	agreement	_
97-17	16811-16816	among	_
97-18	16817-16823	raters	_
97-19	16824-16825	,	_
97-20	16826-16829	and	_
97-21	16830-16832	Pr	_
97-22	16833-16834	(	_
97-23	16835-16836	e	_
97-24	16837-16838	)	_
97-25	16839-16841	is	_
97-26	16842-16845	the	_
97-27	16846-16858	hypothetical	_
97-28	16859-16870	probability	_
97-29	16871-16873	of	_
97-30	16874-16880	chance	_
97-31	16881-16890	agreement	_
97-32	16891-16892	,	_
97-33	16893-16898	using	_
97-34	16899-16902	the	_
97-35	16903-16911	observed	_
97-36	16912-16916	data	_
97-37	16917-16919	to	_
97-38	16920-16929	calculate	_
97-39	16930-16933	the	_
97-40	16934-16947	probabilities	_
97-41	16948-16950	of	_
97-42	16951-16955	each	_
97-43	16956-16964	observer	_
97-44	16965-16973	randomly	_
97-45	16974-16981	staying	_
97-46	16982-16986	each	_
97-47	16987-16995	category	_
97-48	16996-16997	.	_

Text=Contribution of different modalities When scanning the same subject, we can obtain fMRI, sMRI and DTI at the same time.
98-1	16998-17010	Contribution	_
98-2	17011-17013	of	_
98-3	17014-17023	different	_
98-4	17024-17034	modalities	_
98-5	17035-17039	When	_
98-6	17040-17048	scanning	_
98-7	17049-17052	the	_
98-8	17053-17057	same	_
98-9	17058-17065	subject	_
98-10	17066-17067	,	_
98-11	17068-17070	we	_
98-12	17071-17074	can	_
98-13	17075-17081	obtain	_
98-14	17082-17086	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
98-15	17087-17088	,	_
98-16	17089-17093	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
98-17	17094-17097	and	_
98-18	17098-17101	DTI	_
98-19	17102-17104	at	_
98-20	17105-17108	the	_
98-21	17109-17113	same	_
98-22	17114-17118	time	_
98-23	17119-17120	.	_

Text=The multi-modal data provides a different perspective on the study of brain function and structure.
99-1	17121-17124	The	_
99-2	17125-17136	multi-modal	_
99-3	17137-17141	data	_
99-4	17142-17150	provides	_
99-5	17151-17152	a	_
99-6	17153-17162	different	_
99-7	17163-17174	perspective	_
99-8	17175-17177	on	_
99-9	17178-17181	the	_
99-10	17182-17187	study	_
99-11	17188-17190	of	_
99-12	17191-17196	brain	_
99-13	17197-17205	function	_
99-14	17206-17209	and	_
99-15	17210-17219	structure	_
99-16	17220-17221	.	_

Text=In order to investigate which kind of modality is more powerful, we intend to study the contribution of each modality to the fusion data.
100-1	17222-17224	In	_
100-2	17225-17230	order	_
100-3	17231-17233	to	_
100-4	17234-17245	investigate	_
100-5	17246-17251	which	_
100-6	17252-17256	kind	_
100-7	17257-17259	of	_
100-8	17260-17268	modality	_
100-9	17269-17271	is	_
100-10	17272-17276	more	_
100-11	17277-17285	powerful	_
100-12	17286-17287	,	_
100-13	17288-17290	we	_
100-14	17291-17297	intend	_
100-15	17298-17300	to	_
100-16	17301-17306	study	_
100-17	17307-17310	the	_
100-18	17311-17323	contribution	_
100-19	17324-17326	of	_
100-20	17327-17331	each	_
100-21	17332-17340	modality	_
100-22	17341-17343	to	_
100-23	17344-17347	the	_
100-24	17348-17354	fusion	_
100-25	17355-17359	data	_
100-26	17360-17361	.	_

Text=Suppose Xi is the features for subject i.
101-1	17362-17369	Suppose	_
101-2	17370-17372	Xi	_
101-3	17373-17375	is	_
101-4	17376-17379	the	_
101-5	17380-17388	features	_
101-6	17389-17392	for	_
101-7	17393-17400	subject	_
101-8	17401-17402	i	_
101-9	17403-17404	.	_

Text=Then we use the following logistic regression to model the probability, pi, for the i-th subject to be a patient: In order to assess the contribution of different modalities, we use R2 indices, defined by Cox and Snell to describe how well the features Xi fit a set of observations (i.e., goodness of fit).
102-1	17405-17409	Then	_
102-2	17410-17412	we	_
102-3	17413-17416	use	_
102-4	17417-17420	the	_
102-5	17421-17430	following	_
102-6	17431-17439	logistic	_
102-7	17440-17450	regression	_
102-8	17451-17453	to	_
102-9	17454-17459	model	_
102-10	17460-17463	the	_
102-11	17464-17475	probability	_
102-12	17476-17477	,	_
102-13	17478-17480	pi	_
102-14	17481-17482	,	_
102-15	17483-17486	for	_
102-16	17487-17490	the	_
102-17	17491-17495	i-th	_
102-18	17496-17503	subject	_
102-19	17504-17506	to	_
102-20	17507-17509	be	_
102-21	17510-17511	a	_
102-22	17512-17519	patient	_
102-23	17520-17521	:	_
102-24	17522-17524	In	_
102-25	17525-17530	order	_
102-26	17531-17533	to	_
102-27	17534-17540	assess	_
102-28	17541-17544	the	_
102-29	17545-17557	contribution	_
102-30	17558-17560	of	_
102-31	17561-17570	different	_
102-32	17571-17581	modalities	_
102-33	17582-17583	,	_
102-34	17584-17586	we	_
102-35	17587-17590	use	_
102-36	17591-17593	R2	_
102-37	17594-17601	indices	_
102-38	17602-17603	,	_
102-39	17604-17611	defined	_
102-40	17612-17614	by	_
102-41	17615-17618	Cox	_
102-42	17619-17622	and	_
102-43	17623-17628	Snell	_
102-44	17629-17631	to	_
102-45	17632-17640	describe	_
102-46	17641-17644	how	_
102-47	17645-17649	well	_
102-48	17650-17653	the	_
102-49	17654-17662	features	_
102-50	17663-17665	Xi	_
102-51	17666-17669	fit	_
102-52	17670-17671	a	_
102-53	17672-17675	set	_
102-54	17676-17678	of	_
102-55	17679-17691	observations	_
102-56	17692-17693	(	_
102-57	17694-17698	i.e.	_
102-58	17699-17700	,	_
102-59	17701-17709	goodness	_
102-60	17710-17712	of	_
102-61	17713-17716	fit	_
102-62	17717-17718	)	_
102-63	17719-17720	.	_

Text=We denote,,, as the R2 indices of four different models when we use fusion, fMRI, sMRI, and DTI features as independent, respectively.
103-1	17721-17723	We	_
103-2	17724-17730	denote	_
103-3	17731-17732	,	_
103-4	17733-17734	,	_
103-5	17735-17736	,	_
103-6	17737-17739	as	_
103-7	17740-17743	the	_
103-8	17744-17746	R2	_
103-9	17747-17754	indices	_
103-10	17755-17757	of	_
103-11	17758-17762	four	_
103-12	17763-17772	different	_
103-13	17773-17779	models	_
103-14	17780-17784	when	_
103-15	17785-17787	we	_
103-16	17788-17791	use	_
103-17	17792-17798	fusion	_
103-18	17799-17800	,	_
103-19	17801-17805	fMRI	_
103-20	17806-17807	,	_
103-21	17808-17812	sMRI	_
103-22	17813-17814	,	_
103-23	17815-17818	and	_
103-24	17819-17822	DTI	_
103-25	17823-17831	features	_
103-26	17832-17834	as	_
103-27	17835-17846	independent	_
103-28	17847-17848	,	_
103-29	17849-17861	respectively	_
103-30	17862-17863	.	_

Text=We define the contribution of different modality to fusion data as the ratio of R2 of each modality to R2 of fusion data.
104-1	17864-17866	We	_
104-2	17867-17873	define	_
104-3	17874-17877	the	_
104-4	17878-17890	contribution	_
104-5	17891-17893	of	_
104-6	17894-17903	different	_
104-7	17904-17912	modality	_
104-8	17913-17915	to	_
104-9	17916-17922	fusion	_
104-10	17923-17927	data	_
104-11	17928-17930	as	_
104-12	17931-17934	the	_
104-13	17935-17940	ratio	_
104-14	17941-17943	of	_
104-15	17944-17946	R2	_
104-16	17947-17949	of	_
104-17	17950-17954	each	_
104-18	17955-17963	modality	_
104-19	17964-17966	to	_
104-20	17967-17969	R2	_
104-21	17970-17972	of	_
104-22	17973-17979	fusion	_
104-23	17980-17984	data	_
104-24	17985-17986	.	_

Text=For example, the ratio is the contribution of fMRI data.
105-1	17987-17990	For	_
105-2	17991-17998	example	_
105-3	17999-18000	,	_
105-4	18001-18004	the	_
105-5	18005-18010	ratio	_
105-6	18011-18013	is	_
105-7	18014-18017	the	_
105-8	18018-18030	contribution	_
105-9	18031-18033	of	_
105-10	18034-18038	fMRI	_
105-11	18039-18043	data	_
105-12	18044-18045	.	_

